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Abstract 
Since the drug molecules inside human body (in the blood vessel) are recognised as 
being alien, and quickly eliminated or degraded, it is necessary to find a way to protect 
and direct these effective components to the target zone. Therefore, the design and 
preparation of the therapeutic delivery systems in vivo has attracted considerable 
attention in recent decades. Nanocapsules, as a relatively new delivery approach, have 
many advantages. Compared with micron or larger delivery systems, nanocapsules are 
smaller and hence can migrate to diseased organs without blocking the bloody vessels. 
Also unlike nanospheres, nanocapsules could provide more capacity space for the 
therapeutics loading. Therefore, in this thesis the design and preparation of 
nanocapsules for the drug delivery system is discussed. A Layer-by-Layer 
self-assembly method onto nanospheres as a template has been developed. This method 
allows easy control of the size of the capsules and the thickness of the capsule walls; 
moreover, its flexibility has enabled various types of materials to be used to form the 
walls of the capsules, such as polyelectrolytes, proteins and various inorganic particles. 
In this project, two different core templates (silica and polystyrene nanoparticles) were 
prepared. Hollow capsules based on silica nanoparticles (95 nm and 114 nm) were 
obtained from the deposition of 9 layers of Chitosan (CHI) and Dextran sulphate 
sodium salt (DS), subsequently the silica cores were removed by dissolving in an 
HF/NH4F buffer solution. For the nanocapsules based on polystyrene particles (130 nm 
and 480 nm), a layer of the synthetic inorganic clay, Laponite, was introduced to 
improve the strength of the nanocapsules. After the core-removal process (by 
dissolving in tetrahydrofuran THF), a high productivity of hollow nanocapsules was 
observed for both particle sizes. Gold (4-10 nm) and magnetite (10 nm) nanoparticles 
were also incorporated into the capsule walls to modify the properties of nanocapsules 
obtained from the polystyrene nanoparticles of 130 nm; these materials make the 
particles sensitive to near infer red light and a magnetic field respectively. Furthermore, 
nanocapsules consisting of proteins (lysozyme and bovine serum albumin BSA) and 
polyelectrolytes (Poly(diallydimethylammonium chloride) PDADMAC and DS) were 
also fabricated. In the final part of the thesis, loading materials into the nanocapsules 
were tried. Instead of directly loading into the nanocapsules, the insulin was first 
prepared as insulin nanoparticles and these nanoparticles were then coated with the 
polyelectrolyte/protein layers to form the nanocapsules loaded with drug molecules. 
This project has extended the size range of nanocapsules that can be synthesized, and 
also the range of materials, and hence the properties, that can be included in the walls of 
the nanocapsules. 
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Chapter 1 Introduction 
Recently, there has been intense research into the preparation of uniformly-sized 
hollow capsules. Controlled release of material of for various purposes has been the 
main driving force behind the research into these hollow spherical structures [1]. Such 
structures have found application in various research fields including petrochemicals, 
pharmaceutics, agrochemicals and cosmetics [2, 3]. Hollow capsules can also be used 
in catalysis, acoustic insulation, developing low dielectric constant materials and 
piezoelectric transducers, and in the preparation of advanced materials et al [1, 4].  
 
Nanocapsules are one type of hollow capsules with a size range from tenths of 
nanometers to 1000 nm [5, 6]. Due to the small size of these hollow capsules, one of the 
most important applications of nanocapsules is for use in drug delivery systems,  
because the size of the colloid drug delivery systems (CDDS) is one of the most 
important parameters affecting the performance of CDDS in vivo, furthermore it can 
also influence the interaction of CDDS with the environment and the target field [7]. 
Nano-sized capsules can be injected directly into the human body without blocking 
blood vessels [8, 9]. Furthermore, it has been reported by many researchers [10-12] that 
their small size is an advantage, in that smaller CDDS were removed more slowly from 
blood circulation [13]. In addition, it was found that nanoparticles under 200 nm have a 
longer circulation time in the body than larger particles because the high radius of 
curvature of the particle surface prevents the efficient binding of opsonins [13]. The 
combination of long circulation time and small size of the nanocapsules has been 
shown to increase the accumulation of the loaded drugs into the tissues [5]. Also, it 
may be possible to put some targeting ligands [14, 15] onto the capsules and so target 
the drug loaded capsules to directly go to the diseased cells, and reduce the side-effect 
of the drug to the normal tissues. Because of the importance of nanocapsules in drug 
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delivery systems, how to prepare nanocapsules with these demanding properties has 
aroused immense interest.  
 
There are various methods to prepare a wide size range (nanometre to millimetre) of 
stable hollow capsules consisting of different composite materials, including nozzle 
reactor processes, emulsion/phase separation procedures(often combined with sol-gel 
processing) and sacrificial core techniques [4]. However, there are still many 
limitations of these techniques, which prevent the commercialisation of the hollow 
spheres. Some of these limitations come from the process of preparing the hollow 
spheres, e.g. the harsh conditions involved in some methods, and the difficulty in 
introducing materials into the capsules; others are from the properties of the capsules, 
e.g. the lack of control over size, geometry, wall thickness and wall uniformity [1]. The 
sacrificial core technique is the only method that could potentially be used to prepare 
nanometre sized capsules. 
 
An alternative way has been developed to fabricate nanocapsules of uniform size, wall 
thickness, geometry and composition etc., which combines the so called 
Layer-by-Layer self-assembly method onto colloidal particles which act as templates, 
and is then followed by removal of that colloidal particle (the sacrificial core) [1]. In 
this method a charged particle acts as a template and alternating layers of oppositely 
charged polyelectrolytes are successively built up on the particles and finally the 
particle template is removed to leave a capsule.  The mono-dispersed colloidal 
templates determine the diameter of the nanocapsules, and the number of 
polyelectrolyte layers controls the wall thickness of the capsules. Also by the 
Layer-by-Layer method, various composite materials can be combined together to form 
nanocapsules of different physical or chemical properties [16].  
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At the outset of this project this technique was limited to producing small 
microcapsules, 1-100 μm in diameter rather than nanocapsules dozens of nanometers to 
1000 nm. This thesis reports attempts to produce genuine nanocapsules which could be 
usefully used as drug delivery vehicles. Different core templates (silica and polystyrene 
nanoparticles) and capsule materials (polyelectrolytes, inorganic nanoparticles and 
proteins) were utilised in the experiment to make nanocapsules with diverse 
characteristics. The method of synthesizing such capsules was confirmed applicable, 
although no studies of the release of materials have been conducted in this study; an 
outline of the thesis is given below. 
 
In Chapter 2, firstly different therapeutics delivery systems are reviewed and the reason 
for choosing nanocapsules as the drug delivery system is also discussed. Then, various 
methods of preparing nanocapsules are compared and based on the advantages and 
disadvantages of these methods, the Layer-by-Layer (LbL) self-assembly method was 
selected as the main approach in this work to prepare nanocapsules. Thirdly, the 
principles of the LbL method and the mechanism of loading and releasing therapeutics 
are reviewed. Also the core templates and coating materials of the LbL method ware 
discussed. Finally, the motivation and innovation of this PhD project is presented. 
 
In Chapter 3, the characterization methods (zeta-potential measurement, dynamic light 
scattering, CPS disc centrifuge, SEM , TEM, and powder x-ray diffraction) used in this 
project were discussed (including the experiment details, and data and error analysis).  
 
In Chapter 4, the preparation of nanocapsules based on silica nanoparticles templates is 
discussed. Two biocompatible polyelectrolytes were used as the capsule materials in 
the Layer-by-Layer assembly process. Silica nanoparticles with different size ranges 
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were produced in the experiment. The silica core was then removed by HF dissolution 
to make the hollow nanocapsules. 
 
In Chapters 5 and 6, two sizes of polystyrene particle templates were manufactured. 
Both of the polystyrene particles were employed to prepare hollow nanocapsules. For 
the particles with a size of around 480 nm, both synthesis and biocompatible 
polyelectrolyte were used as the capsule materials and the effect of adding the synthetic 
clay, Laponite on the mechanical strength of the capsules was qualitatively investigated. 
For the particles with a smaller size (130 nm), only biocompatible polyelectrolytes 
were employed, moreover the capsules were functionalized with gold and magnetite 
nanoparticles. Nanocapsules of different size were obtained by dissolving the 
polystyrene particles in tetrahydrofuran. 
 
In Chapter 7, the nanocapsules consisting of biomolecules were fabricated. Two 
different core templates: polystyrene and insulin nanoparticles were used in this section. 
For the nanocapsules based on polystyrene particles, 2 protein molecules (bovine 
serum albumin/lysozyme) were used as coating materials and they were added onto the 
polyelectrolyte pre-coated polystyrene nanoparticles. The nanocapsules were formed 
by dissolving the polystyrene template with THF. The insulin particles were prepared 
via a salting out process [17]. After coating with polyelectrolyte and protein, single and 
well dispersed insulin particles were observed in the suspension.      
 
Finally, in Chapter 8, some general conclusions are given and suggestions for further 
research work are provided. 
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Chapter 2 Literature Review 
Before we introduce the main topic of this PhD project, it is wise to review the progress 
of the current development of the drug delivery systems to answer this question why 
choose nanocapsules? 
 
2.1 Drug delivery systems 
Oral taken and subcutaneous or intravenous injection are traditional drug delivery 
methods to introduce drug molecules into human body. By either way, the medicine 
will be absorbed into the blood circulation and circulated all over human body. 
However, because the effective components of drugs are in their molecular state in the 
blood, there are more possibilities for them to meet any situation which could arouse 
their degradation. Thus, only a very small amount could reach the ill tissues and most of 
them are degraded [18]. Therefore, to protect and target these effective components 
attracted many research interests.  
 
The concept of drug delivery and targeting system comes from the works and ideas of 
German chemists in 19
th
 century and they named the system as “magic bullet”. One 
representative icon of them is Paul Ehrlich, who described this system as a compound 
could target an abnormal organism and toxin from the abnormal organism could also be 
delivered by some agent [19]. A drug delivery system as Petkar et al. concluded is to 
help dissolve hydrophobic drug in vivo, reduce drug toxicity, target to specific 
organisms and reinforce the bioavailability and stability of the drugs [20]. To overcome 
the problems of drug uptake encountered in the traditional delivery system, packaging 
the drug molecules with designed carrying system is considered to be one of the most 
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effective ways. So far, many types of drug carrier systems of different size ranges and 
compositions (like micelles and dendrimers [21-23], liposomes [24-26] and 
biodegradable particles [27-30] etc.) have been researched and developed and many of 
them (e.g. micelles (Knakion MM
TM
 ), liposomes (AmBisome
TM
), microemulsions 
(Neoral
TM
), liquid scrystalline structures (Elyzol
TM
) and so on) have been 
commercialized.  
 
During the last two decades, many works have been done on micro-scale drug delivery 
system to either increase drugs’ efficiency or decrease drugs’ side effects [31-34]. 
However, due to the size issue, there are some limitations for the micro-scale drug 
delivery systems. Firstly, for the oral taken system, the size limitation prevents some 
large particles into the lymphatic system through intestinal absorption. Secondly, if the 
drug molecules need to reach certain organism, intraveneous administration is 
generally required and particles as large as micro-meters would easily clog small 
capillary vessels and form aggregation [35, 36]. It is also found nanoparticles with size 
around 200-500 nm are proper for the intraveneous delivery [37]. Also, as 
aforementioned, smaller size of the nanoparticles provide longer circulation time in 
vivo, which can provide the ability of sustained releasing [13, 38]. Therefore, in recent 
years, considerable attention has been focused on the various nanotechnology 
platforms used in the diagnostic and therapy areas [39], and although most of the 
products are still in the research state, nano-scale delivery system (e. g. nanospheres [40, 
41], solid lipid nanoparticles [42, 43] and nanocapsules [44, 45]) have aroused massive 
research interests. 
 
The nano-scale drug delivery system normally refers to nanoparticles less than 1 
micrometer [46] and the nanoparticles could be classified as nanospheres and 
nanocapsules [47]. The composition of the nanoparticles is displayed in the Fig. 2.1. In 
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Fig. 2.1, 5 types of nanoparticles are demonstrated and the first three (from left) belong 
to the category of nanospheres, and the other two on the right are nanocapsules.  
 
 
Fig. 2.1 Different structures of the nano-scale delivery system [47] 
Nanocapsules are a pool form comprising of a shell structure and a core template. 
Normally, the cores are liquid or semisolid at room temperature (15-25 
o
C). The oily or 
aqueous medium inside the nanocapsules provide the nanocapsules with abilities to 
encapsulate hydrophobic (lipo-soluble) or hydrophilic (water-soluble) compounds. 
Likewise, nanospheres, as described in Fig. 2.1, are nanoparticles with entire mass solid. 
These nanoparticles are generally of spherical shape but other kinds of shapes are also 
reported [48-50]. As drug delivery systems, the drug molecules can be either loaded 
inside or attached on the surface of the nanoparticles.  
 
Compared with nanospheres, nanocapsules provide more advantages for drug delivery. 
Considering the drug loading dosage, for nanocapsules, the drug/polymer ratio could 
reach 5:1 when the core is of pure drugs; while for nanospheres, this number is as low 
as 1:10 [51]. Also low content of polymers and protecting activity of loading stuffs 
(such as enzymes and proteins) by providing cavitary space are another two benefits 
when nanocapsules are applied [51].  
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In summary, since there is so many important advantages and applications for the 
nanocapsules in drug delivery system, thus in this PhD project, the preparation of 
nanocapsules of size under 200 nm will be discussed.  
2.2 Review of Other Hollow Capsule Synthesis 
Methods 
Lipid liposomes and vesicles which are fabricated from the self-assembly of 
phospholipids which form closed bilayer systems are a special kind of hollow spherical 
nanocapsules and Liposomes became commercialized in 1986 by Dior [52]. Liposomes 
can be classified as large and small unilamellar vesicles, as well as large multilamellar 
liposomes, depending on the size and number of lipid bilayers [53]. Water-soluble 
compounds can be encapsulated in the interior of the vesicles, and amphiphilic and 
lipophilic compounds can be associated with the lipid bilayers [53]. There are many 
methods to prepare liposomes sizes from 50 nm to a few hundred nanometers. The most 
common ways include extrusion, sonication, solvent injection and reverse-phase 
evaporation [39, 54]. In 1962, Saunders et al. introduced the classical method of 
sonicating a dispersion of phospholipids to form optically clear  small unilamellar 
vesicles suspensions [55]. In 1965, Bangham et al. first reported the preparation of 
liposomes with entrapped solutes [56]. Later Bangham and his colleagues (1974) 
pointed out the fact that large multilamellar liposomes can form spontaneously in 
aqueous solutions [57]. In 1978, Szoka et al. prepared large unilamellar vesicles via 
water-in-oil phospholipid emulsions and the system buffered in an over saturated 
organic phase. The excess organic phase was removed by evaporation under reduced 
pressure [58]. Aboofazeli and Lawrence (1991 and 1993) exploited the preparation of 
lecithin-based microemulsions; because lecithin is likely to form liquid crystalline 
structures in water solution [59], a cosurfactant was needed to stabilize the emulsion 
and the system water-lecithin-alcohol-isopropyl myristate was employed in their 
research [60, 61]. Later, Lawrence et al. extended their research on the lecithin and used 
either an alkanoic acid, amine, alkanediol, polyethylene-glycol alkyl ether or alcohol as 
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the co-surfactant [62] and the influence of the surfactant was also exploited [63]. Due to 
the very low toxicity of the liposome systems for in vivo applications [39], DNA/RNA, 
proteins and drug delivery system using liposomes as carriers [64-68] have been 
developed. Therefore, liposomes are widely used in biophysics, pharmacology and 
medicine, cosmetics, chemistry and protein studies, food industry and etc [69].   
 
However, there are some limitations related with the stability and permeability of 
liposomes, which restricts the applications of liposomes [1]. The main limitations of the 
liposome system are listed below: 1) easily degraded by lipases or flagellated by 
opsonin followed by macrophage uptake; 2) thermodynamic instability, vesicles are not 
usually in an equilibrium state, and could be easily trapped in a meta-stable shape 
during formation [70]; 3) low permeability of polar molecules [71]; 4) poor storage of 
water soluble components in bloodstream [72]. 
 
Therefore, compared with liposomes, polymeric materials which can provide more 
stability of encapsulation and controlled releasing have aroused extensive research 
interest [72].  
 
As was mentioned in the introduction, there are several chemical and physiochemical 
ways to prepare the hollow spherical structures of different size ranges. These methods 
were summarised and reviewed by Caruso [1] and Wilcox et al[4]. A brief description 
is presented in the following paragraphs: 
 
The sacrificial core method: the core templates are firstly coated with the required 
materials via surface reaction or controlled precipitation of molecular precursors. Then 
the hollow spherical shell could be obtained by a core-removal process, either by 
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thermal (volatilization) or chemical (dissolving) means [1, 4]. In 1991, Kawahashi et al. 
prepared hollow spheres consisting of yttrium compounds by the core-sacrificial 
methods[73]. They prepared polystyrene particles (170 nm) with positive surface 
charges and adsorbed particles of yttrium basic carbonate on their surface. Then the 
polystyrene particles were removed by calcination in air and hollow capsules of yttrium 
oxides which transformed from yttrium basic carbonate were obtained[73]. 
 
Nozzle reactor methods: The prepared liquid is quickly pushed through a spray drying 
nozzle and liquid droplets of 10-500 µm can be produced. Then by heating (spray 
drying) or cooling (freeze drying) the droplets created previously the moisture of the 
liquid is removed, and the shape of the spheres could be consolidated [1, 4]. Bruinsma 
et al. prepared mesoporous fibres and hollow capsules by rapid spray-drying 
hydrolyzed silicon alkoxide solutions. Then the fibres and capsules were calcined [74]. 
They also used different ratios of silica-to-surfactant in the solution to modify the pore 
size of both the mesoporous fibres and hollow capsules. However, the size of the 
hollow particles was widely distributed (from 1 micron to tens of microns) and certain 
part of the capsules collapsed after the calcinations [74].  
 
The emulsion/phase separation approach (often combined with sol-gel processing): 
This technique firstly involves the formation of an emulsion based on the principles of 
surface and interfacial tension forces and immiscibility between phases. Then, the 
spheres are separated from the liquid medium, which is then followed by methods to 
convert them into rigid hollow spheres. The separation is normally of different 
chemical or physical ways, such as liquid extraction etc [1, 4]. For example, in 1996, 
Schacht et al. prepared hollow silica capsules by hydrolysing tetra-ethoxysilane (TEOS) 
at the oil-water interface[75]. In their experiment, a mixture of mesitylene, water, 
surfactant and TEOS was stirred and the TEOS molecules were encapsulated within the 
formed mesitylene droplets. Then the TEOS molecules were hydrolyzed at the surface 
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of oil-water and a silica shell was gradually formed. Finally, hollow capsules consisting 
of silica were obtained [75]. 
 
However, there are several disadvantages in all of the methods mentioned above [1, 76]. 
Because of the harsh conditions in some methods, it is inappropriate for loading 
sensitive materials such as pharmaceuticals. Once the capsules formed, it is difficult to 
encapsulate any new materials into the capsules. Others issues include lack of control 
over wall thickness, size, geometry, and wall uniformity of capsules, which will in turn 
affect the potential use of the hollow capsules. 
 
To overcome the disadvantages of these methods of synthesising hollow capsules, a 
new technique, the Layer-by-Layer self assembly method, has been introduced. The 
concept and development of the technique will be discussed in the following sections.  
 
2.3 Nanocapsules Synthesised via the 
Layer-by-Layer Self-assembly Method 
2.3.1 The Principles of the Layer-by-Layer Method 
The Layer-by-Layer self-assembly method has many advantages for making thin 
polymeric layers on surfaces and hence capsules, such as this method is easy and cheap 
and is capable of employing various different materials. The basic principle of the 
Layer-by-Layer (LbL) method is to utilise electrostatic interactions between oppositely 
charged polyelectrolytes, or other materials, to fabricate thin uniform multilayers onto 
the original substrates.  
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In 1941, Langmuir discussed the idea of adsorption of ions onto a surface to form a 
single layer, and also demonstrated the experiment by adsorbing a single layer of 
thorium ions onto a monomolecular layer of barium stearate [77]. In the 1960s, Iler 
utilised this strategy to build up alternating layers of positively charged alumina fibrils 
and negatively charged silica colloids onto a smooth glass surfaces [78]. In the early 
1990s, Decher and colleagues exploited this method and prepared multilayers of thin 
films by immersing a charged planar surface (silicon wafer or quartz) alternately into 
anionic and cationic polyelectrolyte or bipolar ampholyte solutions [79-81]. They used 
macroscopic planar silicon wafers and quartz surfaces, which are negatively charged, 
as the templates, and immersed the substrate initially into a solution containing a 
cationic polyelectrolyte. After that, a monolayer of polyelectrolyte was found to be 
adsorbed onto the surface of the solid. After rinsing, the solid was then immersed into 
another solution with an anionic polyelectrolyte. Again a monolayer was adsorbed and 
the original surface charge was restored [79, 80]. The Layer-by-Layer self-assembly 
method may be simply demonstrated in Fig. 2.2. Decher et al. demonstrated that 
multilayers films composed of at least 100 consecutively alternating layer can be 
assembled in this way. After the build up of the multilayer film UV/vis spectroscopy 
and small angle X-ray scattering (SAXS) were employed to investigate the property of 
the film [82]. Then Decher et al. applied this method to fabricate smectic multilayer 
films by transferring freely suspended (FS) or liquid-crystalline (LC) layers onto the 
solid support [83].  
 
After that, the LbL method was adapted by many other groups and more and more 
materials such as functional polymers, orientable chromophores, inorganic particles, 
clays, dyes, and biomolecules such as DNA and proteins, were employed to fabricate 
these multilayers [1, 84-87]. Because many diverse materials could be involved in the 
LbL method, and since the LbL method can be combined with other assembly 
processes, there is a high application potential for the LbL process in materials 
development [88-90]. The multilayer structure can be used as matrix materials for 
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functional or biological molecular entities, such as separation membranes, sensor 
applications and customised surface modification [88, 91, 92].  
 
 
Fig. 2.2 The diagram shows the process of the LbL method [93] 
 
2.3.2 Application of Layer-by-Layer Self-assembly 
Method on Preparation of Micro- and Nano-capsules  
Due to the versatility of the LbL methods, it seems possible to build the multilayer onto 
higher dimensional surfaces, i.e. non planar surfaces. However, as it was mentioned in 
the last section, after Decher’s pioneer works in the utilizing LbL self-assembly method 
to prepare multi-layer thin films, there has been a plethora of studies using various 
materials as layer components to prepare multilayer films [94-99] and most of the 
research works were based on charged planar surfaces such as quartz or silicon wafers. 
It was not until 1998 that Sukhorukov [100] and Donath [71] demonstrated their work 
on transferring the Layer-by-Layer method from macro planar templates to charged 
colloidal particles in aqueous solution. Their work introduced one of the most 
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important adaptions of the LbL methods: the application of preparing micro- or nano- 
capsules. Since 1998, many research works focusing on the application of 
Layer-by-Layer method on colloidal templates have been undertaken and colloidal 
cores of various composition (latexes, inorganic oxides, carbonates, phosphates and 
even cells) and size (nanometre–micrometer range) have been coated with multilayer of 
diverse composition and controllable thickness [71, 101, 102]. A common application 
of the core–shell particles produced via the LbL strategy is the formation of hollow 
multilayer capsules, obtained after removal of the templating cores by either, chemical, 
or thermal means [71, 101, 102]. The credit of building up the whole process has been 
given to Caruso and his co-workers’ pioneer work in this area [71, 100, 102, 103].   
 
The basic principle of the LbL method is to sequentially deposit oppositely charged 
macromolecule pairs onto charged colloidal particles. It is comprised of several steps as 
outlined in Fig. 2.3. 
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Fig. 2.3 shows procedures for hollow nanospheres production via Layer-by-Layer self-assembly 
methods [1]. 
 
In Fig. 2.3, before step one is the process of preparing the colloidal templates. For the 
LbL method, the colloidal templates can have different sizes (ranging from 
sub-micrometer to micrometer regime), composition, and shapes. The first step (1) is 
the deposition of charged polyelectrolyte onto the charged particle surface. The 
polymer layer which has the opposite charge to the particle surface adsorbs onto the 
particle by electrostatic forces. The excess unadsorbed polymers are removed by a 
centrifugation and rinse cycle; repeating the cycle in step 1 with polymers (step 2) or 
nanoparticles (step 3) results in another polymer, or nanoparticle, layer deposition. The 
rest of the layers can be deposited by repeating steps 2 and step 3. After the core-shell 
structure with the desired size, shell thickness, and composition has been fabricated, the 
core templates need to be removed to make the final capsules. Depending on the 
property of the core templates, the cores can be removed either by thermal (calcination) 
(step5) or chemical (solvent) process (step 4 and step 6): 
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1) The thermal method employs calcination where a very high temperature is 
applied and so can only be used if inorganic nanoparticles (shell materials) 
have been incorporated into the systems. The organic cores and any polymers 
are burnt out. After the calcination, only hollow inorganic shells can remain 
[104]. 
2) The chemical method removes the core templates by dissolving or reacting 
away the cores. After dissolving, hollow polymer (or inorganic) shells can be 
obtained [104]. 
 
2.3.3 Advantages of Layer-by-Layer Self-assembly 
Strategy 
In summary, according to Caruso et al [71, 105], there are five main advantages of the 
LbL strategy, and all the advantages are listed below: 
The electrostatic and steric interaction involved in the LbL method could pass to the 
colloids after each layer coating, which could make the colloid more stable to any 
physical or chemical influence than the colloids prepared from any other approach.  
Due to the high flexibility of choosing core templates and shell materials, the 
composition of the core-shell structure can be controlled and manipulated according to 
their ultimate usage. 
By changing the number of layers, the wall thickness of the capsules can be controlled 
at nanometre level. 
By controlling the template size, the capsule size can be controlled. 
The capsules prepared from the LbL process have a relatively more flexible structure 
and maybe manipulated to be permeable to polar molecules (size up to several 
nanometers).  
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2.3.4 Encapsulation 
Many techniques have been proposed to encapsulate effective components using the 
hollow capsules prepared via the LbL self-assembly method. In general, the drug 
components could be encapsulated by two primary processes: pre-loading and 
post-loading [106]. Three most used techniques are demonstrated in Fig. 2.4 [107]. In 
this diagram route A belongs to the post-loading process, while B and C are subject to 
pre-loading method.  
 
Route A is a straightforward approach to load drug molecules after the hollow capsules 
have been prepared. In this route, the drug molecules are loaded into the capsules by 
diffusing from the medium in which the capsules are dispersed. The loading concept 
behind this route is that if the polyelectrolytes comprising the capsules are sensitive to 
pH (e.g. poly(allylamine hydrochloride) (PAH)/poly(styrene sulfonate) (PSS)) [108] or 
ionic strength (e.g. PAH/dextran sulfate) [109], by changing the pH or salt 
concentration of the medium, there will be the pores formed with the shells and drugs 
could be loaded through those pores [107]. De Geest et al. also pointed out that when 
pH of the medium is close to the apparent pKa of one of the polyelectrolyte pair, the 
binding of polyelectrolyte layers will become weak and lead to increased permeability 
of the capsules [106]. Many studies has been performed by employing the concept of 
the route A [108, 110-112]. For example, in 2005, Ye et al. used acridine hydrochloride 
(AH) as the loading and releasing materials to test the properties of the nanocapsules 
consisting of chitosan (CHI) and sodium alginate (ALG) at pH 7.4 [113]. Furthermore, 
it has been reported that low molecular weight substances (less than 5kDa) could freely 
pass through the wall (in or out) of nanocapsules and any larger macromolecules did 
not easily pass through [111]. 
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Fig. 2.4 Techniques for encapsulating therapeutics: A) loading after the capsule formed; B) 
encapsulate crystal particles C) components preloaded in porous particles [107]. 
To solve this problem, the electrostatic loading mechanism is normally employed [37]. 
In this mechanism, oppositely charged compounds (in capsule) are utilised to attract the 
low molecular compounds designed to be encapsulated and the low molecular 
compounds will accumulate inside the capsules due to electrostatic interaction. 
Because the molecules to be encapsulated are combined with the opposite charged 
compounds, the concentration of the “free” molecules is lower than it is in the medium 
and the drug molecules will continually diffuse into the hollow capsules until reaching 
equilibrium. Thus in this case, a relatively higher concentration of drug molecules 
inside the capsules could be obtained. Sukhorukov et al. introduced this method and 
used this principle to load dyes into hollow capsules (8 µm) [114]. Then, Tao et al. 
reported the work which introduced the anti cancer drug doxorubicin (DOX) (cationic 
charged) into hollow polyelectrolyte capsule (7.8 µm) consisting of sodium alginate 
(ALG) and chitosan where the driving force used was the electrostatic interaction 
between doxorubicin and ALG [115]. Khopade and Caruso also reported the research 
work utilising DOX as the loading components and they used a two-step loading 
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process to achieve the result. In the first step, dextran sulfate (DS) was encapsulated 
into the hollow capsules (3.5 µm) consisting of poly(styrenesulfonate) (PSS) and a 
fourth generation poly(amidoamine) dendrimer) by diffusion. Then, DOX which is 
positively charged, was loaded through the interaction with DS [110]. There is one 
main challenge for this approach: finding a suitable sequestering agent (the component 
initially loaded) which not only has a high affinity for the drug molecules but also is 
biocompatible [107]. In the first part of this thesis (Chapters 4, 5 and 6), the methods for 
the preparation of hollow nano-capsules, as opposed to micr-capsules, for the 
post-loading therapeutic will be presented. 
 
Route B indicates the process that polyelectrolyte multilayers could be directly 
deposited onto the preformed therapeutic particles (e.g. drugs or proteins) [3, 116]. In 
this route, it is essential for the therapeutic crystal to remain insoluble in the condition 
of polyelectrolyte multilayers’ deposition. Since in most of the situations, the 
deposition of polyelectrolyte onto the crystal surface occurred in an aqueous 
environment, the crystals comprised of hydrophobic substances are preferred [107]. 
Many relevant studies have been reported of this approach [3, 116, 117].  Caruso et al. 
(2000) reported the encapsulation and release of pre-formed enzyme (catalase) crystal 
by polyelectrolyte microcapsules consisting of PAH and PSS. The catalase was firstly 
prepared by salting out method and formed cuboid crystals. These crystals were then 
alternatively coated with fluorescently labeled (Fluorescein isothiocyanate, FITC) 
PAH and PSS multilayers and the coated catalase was then released by changing the pH 
of the solution. Finally, the microcapsules (approx. 20 μm) with minor enzyme residua 
were obtained [116]. Trau et al. then (2002) reported their work on hydrophobic drug 
molecules. They encapsulated organic microcrystalline fluorescein diacetate (FDA) 
(around 1μm) with PAH and PSS multilayers. Then FDA molecules were then released 
by exposure to a releasing agent containing dimethyl sulfoxide (DMSO) and NaOH 
solution [117].The main advantage of this method is by encapsulating therapeutic 
crystals, the therapeutics can be highly concentrated [107]. However, one limitation of 
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this strategy is that only a few compounds form crystals which can be used as core 
templates [107]. Hence, to overcome this limit, some groups reported experiments 
employing protein aggregates (e.g. chymotrypsin [118] and dehydrogenase [119]) as 
core templates. Many groups had reported their works of this strategy and various 
materials (e.g. ibuprofen, vitamin K3, biotin) had been used to prepare this core-shell 
structure [120-124]. All these studies indicate that the existence of the LbL capsules 
decreased the releasing rate of the drug molecules.  
 
In this work (Chapter 7), encapsulation of protein nano-aggregates have also been 
carried out. Insulin nano-aggregates were prepared by salting-out procedure and coated 
with combination of lysozyme and dextran sulfate.  
 
Route C represents a very versatile technique of the LbL self-assembly method. This 
method employs porous particles and the therapeutics can be loaded into pores of the 
porous templates before the capsule materials are deposited onto the particles’ surface. 
The large surface area of the particles leads to high loading dosage of therapeutic 
molecules and this method has been applied to various materials of a wide size range 
(from protein to some low molecular drugs) [125-130]. The LbL layers can protect the 
encapsulated components from deactivation or degradation, thereby increase the 
loading dosage, activity and stability of the therapeutics, e.g. demolishing the access 
between enzyme and proteolysis [125]. After the coating process, the porous core 
templates such as silica [130] or calcium carbonate [127] could be removed and the 
conditions used in core-removal process must be friendly to the loaded components. 
For example, in 2006, Itoh et al. employed mesoporous silica particles (several microns 
in diamter) as core-templates and used chitosan and dextran sulphate as capsule 
materials to prepare biodegradable hollow capsules [131]. They firstly mixed the 
porous silica particles with protein solution (fluorescein isothiocyanate labelled 
albumin) to encapsulate protein into the particles. Then the loaded particles were 
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treated with the LbL process and exposed to chitosan and dextran sulphate alternatively. 
6 or 7 layers of biocompatible polyelectrolyte were coated onto the silica particles to 
encapsulate both silica particles and protein. The core template was then removed by 
dipping in the aqueous HF solution. The whole process is summarised in Fig. 2.5. 
 
Fig. 2.5 The fabrication of biocompatible hollow capsules and the loaded protein releasing system 
[131]. 
         
2.3.5 Releasing of Loaded Components 
Once the capsules are loaded with therapeutic components and delivered to the targeted 
area, the loaded therapeutics can be released by two methods: immediately (burst 
release) or gradually over a long period (sustainable release) [107]. Normally, burst 
release is for a delivery system designed for intracellular uptake (such as chemotherapy 
and gene transfection) and sustainable release is appropriate for systems releasing 
effective components outside the cells, in which the instant high concentration of drugs 
may be dangerous and the concentration of drugs must be kept at certain level (for 
example, the treatment of diabetes or schizophrenia [132]. 
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2.3.5.1 Burst release 
Burst release refers to the release mechanisms of remote functionality [37], in which 
the degradation of the nanocapsules could be triggered by external forces (e.g. light 
[133-135], magnetism [136] or ultrasound [137, 138]).  
 
Light stimulation is one of the most popular methods to trigger the “explosion” of the 
capsules. It was first reported by Tao et al (2004) [139, 140] that hollow capsules 
consisting of Congo red (an azo dye) and different polyelectrolytes (PSS, PAH and et al) 
are sensitive to visible light. By illuminating with visible light for 120 min, it was found 
that the structure of the multilayer was slightly adjusted and the permeability of the 
capsules was increased to allow fluorescently labeled dextrans (molecular weight up to 
464 KDa) to pass through [139]. However, due to the long illumination time (120 min) 
and low penetration of visible light to human body, the visible light triggering 
mechanism is not suitable for in vivo application.  
 
Because the human body is almost transparent to the near-infrared laser (800-1200 nm 
[140]), the utilisation of near-infrared can both remote control the drug release in vivo 
and eliminate the side-effects of the radiation to the normal tissues [37]. Hence, many 
recent studies have been undertaken employing near-infrared as a triggering source 
(Fig. 2.6 simulates a releasing process triggered by near-infrared laser). As is illustrated 
in Fig. 2.6, to trigger the nanocapsules with near-infrared light, the polyelectrolytes 
must be incorporated with inorganic nanoparticles [134, 141-145] or infrared dyes 
[141]. In this process, the inorganic (e.g. gold) nanoparticles/ dyes can absorb and 
transform the energy to heat which would affect the original integrity of the 
polyelectrolyte layers [140]. Radt et al [134] and Angelatos et al [133] reported theirs 
works on gold/polyelectrolyte nanoparticles and according to their results, this 
composition could absorb heat from a short near-infrared laser shining and the heat 
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could destroy the capsule itself. In Radt’s work, it had also been observed that the 
energy of the near-infrared light barely affected the activity of lysozyme encapsulated 
inside of the capsules [134].  
 
Fig. 2.6 Demonstration of burst release of nanocapsule consisting of polyelectrolyte and gold 
nanoparticles triggered by laser [107] 
 
Besides near-infrared sensitive polyelectrolyte capsules, there are also other 
photo-sensitive drug carrier systems (e.g. liposomes and polymer micelles) being 
developed [146, 147]. For liposomes, the principle of the light stimulating releasing is 
related to the destabilization aroused by the light irradiation. De Geest et al. based on 
other group’s works summarised the main reasons which induced this destabilization: 1) 
degradation of lipids due to some reactive species (e.g. singlet oxygen) [148, 149], 2) 
photo-isomerization [150] or 3) photo-polymerization [151] of lipids. For polymer 
micelles, the mechanism of burst releasing could be attributed to a photo-chemical 
reaction which leads to changes of the hydrophobicity of the component polymers [152, 
153].  However, most of the photo-sensitive liposomes and polymer micelles are 
responsive to light sources with wavelengths shorter than near-infrared and in this 
wavelength range the UV light is harmful and demonstrates nearly no penetration (<0.5 
mm) to the human body [140]. Furthermore, it has been reported that the intracellular 
uptake capsules could also be triggered to release components by the near-infrared laser 
[143]. By adjusting to an appropriate laser power, the capsules could be collapsed 
without impairing the cell [154].  
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In this project, polyelectrolyte nanocapsules incorporated with gold nanoparticles were 
prepared to endow the nanocapsules with ability of absorbing energy from 
near-infrared sources. 
 
2.3.5.2 Sustainable release 
In general, the drug release rate is dependent on the permeability of the hollow capsules 
and this permeability is mainly decided by the properties of the constituent polymers. 
Those properties could be affected by the changes of the environment such as pH, 
temperature, or ionic strength [108, 155-161]. Therefore, therapeutics could be 
sustainably released either by changing the conditions of the bulk solution, or by 
gradual degradation of the capsule itself [107]. The first route is similar with the 
post-loading process described in the encapsulation section, only with a reverse 
direction of diffusion. As two main reasons affecting the permeability of the capsules, 
many studies have been performed on the pH and ionic strength of the capsules 
dispersion medium [107, 162, 163]. Caruso and Schuler first reported the relationship 
between the ionic strength and the stabilisation of capsules [164]. They fabricated 
capsules consisting of DNA and spermidine onto melamine formaldehyde core 
templates and then the core templates were removed by exposure to an acid 
environment (pH 1.6). The hollow capsules were found to be sensitive to the ionic 
strength of the medium and it was observed that the interaction of DNA and spermidine 
decreased with an increase of the ionic strength. Finally, when the salt concentration 
reached 5 M, the capsules of DNA/spermidine were found completely dissolved [164]. 
Then Ibarz et al. reported their research work of permeation of polyelectrolyte capsules 
at different salt concentrations [112]. In their work, hollow capsules consisting of 
PSS/PAH were prepared and the polymer PAH labelled with rhodamine B (PAH-rho) 
was used as loading/releasing material. It was found that along with an increase of the 
salt concentration in the bulk solution (from 10
-4
 to 2*10
-2
 M), both the 
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loading/releasing speed and amount of PAH-rho increased significantly [112]. 
However, due to the properties of the capsule materials, sometimes the sudden change 
of the environment would result a rapid release of the loaded material [128, 160]. 
Therefore gradually dissolution of the nanocapsules is the other route to achieve 
sustainable release. A typical example is that reported by Itoh et al. on 2006 [131]. As a 
continuous part of the experiment which was mentioned previously, Itoh et al. provided 
a sustainable way to release the loaded material in biodegradable hollow capsules. In 
this part of the experiment Itoh et al. introduced the enzyme (chitosanase) to degrade 
the capsule membranes (contains chitosan and dextran sulphate) and a controlled 
releasing of the loaded protein was achieved (Fig. 2.7).  
 
Fig. 2.7 Release figure of FITC-albumin from hollow capsules of different polyelectrolyte 
combination at different temperatures, CT and Dex in the figure correspond to CHI and DS in this 
thesis [131]. 
 
From Fig. 2.7, it is found that capsules of (CHI/DS)3 at 37℃ presented the highest 
releasing ability of the four batches of samples. It was explained by Itoh et al. that the 
negatively charged DS is more likely to attract chitosanase which is positively charged 
in the solution; therefore in that case more enzymes gathered at the capsules surface and 
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led a quick release of the loaded proteins. It was also noticed that at the same 
temperature (37 ℃), addition of the enzymes would result in a faster releasing rate. 
Furthermore, from Fig. 2.7, chitosanase at 4℃ has a relatively low activity and the 
releasing rate at this temperature is the lowest in this graph, implies that the protein was 
prevented from diffusing through the CHI/DS membrane at this temperature. 
 
In this work, the two main polyelectrolyte used are chitosan and dextran sulphate and 
both of the materials are biodegradable, which ensures various applications for the 
nanocapsules prepared in this project. 
 
2.3.6 Core Templates and Coating Materials 
2.3.6.1 Core Templates 
In the LbL method, the size and morphology of the micro- and nano-capsules are 
mainly affected by the dimension and shape of original core templates. Different 
colloidal particles have been used as core templates.  In this section, the works of the 
most popular colloidal core templates are reviewed in the following sections. There are 
mainly two types of colloidal particles (organic and inorganic) that could be used as 
core templates. 
 
Organic Core Templates 
Melamine Formaldehyde 
Due to the property of easily being dissolved in acidic environment, melamine 
formaldehyde colloidal particles are one of the generally used cores for the LbL 
self-assembly process. As a pioneer scientist in the area of LbL method preparing 
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micro- or nano-capsules, in 1998, Donath et al. reported the fabrication of 
microcapsules consisting of polyelectrolyte on weakly cross-linked melamine 
formaldehyde (MF) colloidal particles [71]. In their experiment, MF particles of 2 and 
3.2 µm were used as core templates and poly(sodium styrenesulfonate) (PSS) and 
poly(allylamine hydrochloride) (PAH) were sequentially added onto MF particles. 
After the polyelectrolyte’s deposition, the MF particles were then removed by exposure 
to an acidic media (<pH 1.6) [71]. After Donath’s work, many studies have been 
performed with MF core templates [165-169]. In these works, different polyelectrolyte 
pairs had been used to prepare the hollow capsules for various applications. Caruso et al. 
(1999) reported experimental work employing a special kind of synthesised 
polyelectrolyte: metallosupramolecular polyelectrolyte to prepared microcapsules. 
Fe(II) metallosupramolecular polyelectrolyte (Fe(II)-MEPE) and poly(styrenesulfonate) 
(PSS) were deposited on MF particles of 1.7 μm and the MF cores of the core-shell 
structures were also dissolved in acidic solution (pH=1) [165]. Khopade et al. (2004) 
provided a new method named, the core-mediated LbL process, to prepare 
microcapsules via MF core templates (1 or 3.5 μm) [166]. In this method, after the first 
layer (PSS) deposition, the MF cores were gradually dissolved in a mild acidic 
environment (pH=4) and spontaneously the MF molecules derived from the core 
decomposition formed the second layer. Then after repeating this cycle, the capsule 
could be built on the partially dissolved cores and the final core templates were 
removed in HCl solution (pH=1) [166]. However, most of the hollow capsules 
produced via MF cores are located within the micron size range, to the best knowledge 
of the author of this thesis, no works of submicron or nanometre size range had been 
reported.  
 
Polystyrene 
Polystyrene colloid is another organic core template widely used in the LbL method. 
Like melamine formaldehyde colloidal particles, polystyrene particles are also 
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relatively easy to be removed. As the first few groups reported the adaption of 
Layer-by-Layer process onto colloid templates, Sukhorukov et al. (1998) demonstrated 
that the multilayer films can also be obtained by deposition of polyelectrolyte onto 
charged latex particles in aqueous solution [100]. They used polystyrene latex particles 
(from 640 nm to 3 μm) as the core templates and tried two pairs of polyelectrolyte, 
namely sodium poly(stryrene sulfonate), poly(allylamine hydrochloride) and 
poly(diallyl dimethyl ammonium chloride) and DNA as the polyelectrolyte layer 
materials. They also employed a centrifugation-based technique to separate coated 
polystyrene particles from bulk solution to avoid large particle aggregates and this 
technique was then widely used in the LbL process. However, as an early work of this 
area, no hollow capsules were produced [100]. To remove the polystyrene core 
templates, two methods had been provided including: chemical dissolving and 
calcination. Chemical dissolving could be used for the capsules consisting of 
polyelectrolytes and the calcination is for the ones comprised of inorganic materials. As 
a good example for both core-removal methods, Caruso et al. (1998) prepared 
silica-polymer spheres on the polystyrene templates of a size scale from720 to 1000 nm. 
By alternatively adding polymer and silica nanoparticles onto the polystyrene core 
templates, uniform core-shell structures were fabricated. Then the polystyrene particles 
were removed by either solvent (tetrahydrofuran THF) dissolution or calcination, two 
types of hollow capsules were obtained. Silica-polymer hollow spheres were obtained 
from chemical dissolving and silica hollow capsules were obtained from the calcination. 
However, both broken and intact hollow capsules were found after both core removal 
methods[102]. Then, along with the tremendous interests had been put into the 
preparation of nanocapsules via the LbL method, polystyrene colloid particles were 
widely used as core templates and hollow capsules of submicron size and various shell 
composition were prepared [102, 170-173].  
 
However, there is one advantage of the organic core templates. Many studies have 
mentioned that after the core removal process, a residue of organic cores is likely to 
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remain inside the capsules and may crosslink with the polymer shell [167, 169]. And 
due to their relatively large molecular weight and quickly being dissolved, the osmotic 
pressure is relatively large while the core removal process and might result capsule 
disruption [174].  
 
Inorganic Core Templates 
Compared with the organic core templates, the inorganic core templates are more 
attractive for the low molecular weight (normally less than 5KDa) of the molecules 
derived from the core removal process.  
 
Inorganic Carbonates 
Many inorganic carbonates had been used as core templates for the LbL process, 
including cadmium carbonate (CdCO3), manganese carbonate (MnCO3) [175] and 
calcium carbonate (CaCO3) [176]. All the inorganic carbonates colloidal particles could 
be removed by ethylene-diamine-tetra-acetic acid (EDTA) and HCl solution [175, 176]. 
However, so far, as reported most of the hollow capsules prepared via the inorganic 
carbonates are within micron size range. 
 
Silica nanoparticles  
Silica particles (both porous and non-porous) have aroused much attention in the LbL 
process for two main reasons. One is the mono dispersed sample could be easily 
obtained from commercial suppliers or laboratory preparation. The other is the particles 
are stable at all pH’s. This is very important for some polyelectrolytes which need 
acidic solution to dissolve e. g. chitosan or the layer deposition process involves 
hydrogen bonding [177, 178]. One important limitation for silica core template is the 
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solvent (HF) used to dissolve the silica cores. HF is very toxic and needs extreme care 
to remove completely from the system. However, as Shu et al. [38] and Itoh et al. [131] 
reported, the attendance of HF does not affect the activity of the pre-loaded protein or 
enzyme and in this project, the post-loading strategy is employed to provide adequate 
washing cycle to get rid of the HF residue. In this case, the impact to the loading 
therapeutics and human body could be minimised.  
 
In summary, because the aim of the project is to prepare nano-scale drug delivery 
system, the core templates must be within the size range of submicron (dozens to 
hundreds of nanometres). Thus, the silica and polystyrene nanoparticles were selected 
as the core templates.  
2.3.6.2 Polyelectrolytes 
Due to the high flexibility of the LbL process, there is a very wide range for the 
selection of the shell materials. DNA [164], proteins [172], inorganic particles [170], 
synthesis polyelectrolytes [170] and biopolyelectrolyes [113] are all reported as capsule 
materials. Since the nanocapsules would be degraded either outside or within the cells 
[106]. They must be produced under certain requirements (also apply to substances 
after degradation): non toxic, biodegradable and non immunogenic [47]. 
 
The main polyelectrolyte pair in this PhD project is chitosan and dextran sulphate. They 
are both biodegradable and attractive for biomedical applications [179]. Two synthetic 
polyelectrolytes PDADMAC and PSS have also used as substitutions for CHI and DS 
for some special situations and they are both biocompatible [140, 180]. Two proteins 
BSA and lysozyme are both naturally extracted proteins. The inorganic nanoparticles 
used in this project are gold, magnetite nanoparticles and both of them were confirmed 
as biocompatible materials [107, 181]. Laponite nanoparticles which were widely used 
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for the design of biosensors [182-184] were employed to strengthen the nanocapsules 
prepared in this project.  
 
2.4 Summary of the Motivation and Innovation 
of this PhD Project 
To ensure the therapeutics could be properly protected in the human blood circulation 
and to make components more effectively cure the ill organs, a useful drug delivery 
system is desired to be developed. As it was discussed in section 2.1, compared with 
other routes there are many advantages of the nano-scale drug delivery system. Thereby, 
in this thesis, the preparation of drug delivery systems on nano-scale range will be 
discussed. Due to the advantages such as easy control of the size and wall thickness, 
various composition and simple process of assembly, the Layer-by-Layer 
self-assembly method is utilised in this project. In this project, the nanocapsules 
(100-200 nm) via silica and polystyrene nanoparticle templates were prepared and this 
size range is an innovation for nanocapsules prepared by LbL process. The combination 
of low molecular weight chitosan and dextran sulphate gives more flexibility to the 
nanocapsules produced and is originally from this research. Also the utilising of two 
oppositely charged proteins and coating the insulin nanoparticles with biodegradable 
polyelectrolyte (DS) and protein (lysozyme) are both innovations of this project.  
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Chapter 3 Characterization Methods 
In this Chapter, the principles of the main characterization methods utilised in the 
project are briefly described, together with the specific details which were actually used 
in making the measurements. 
 
3.1 Zeta-Potential Measurement   
In this project, the zeta-potential was used to monitor the deposition of each 
polyelectrolyte (or other material). Colloidal particles dispersed in a polar solvent such 
as water, or an electrolyte solution, are generally electrically charged (Fig. 3.1).  
 
 
Fig. 3.1 A schematic of the Double Layer of Colloidal Particles [185] 
 
As Fig. 3.1 shows, each particle dispersed in a solution will attract counter ions around 
it, and these attracted counter-ions form a flexible shell. The innermost part of the shell 
is a tightly attached layer of counter-ions, known as the Stern Layer [186]. Outside the 
Stern Layer, there are also some counter-ions that are affected not only by the 
attraction from the particles but entropy which is trying to disperse the ions. So these 
counter-ions form a cloud-like area, which has high concentration of counter-ions near 
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the Stern Layer surface and exponentially decreases with the distance away from the 
particle surface to infinite until reaching equilibrium, again with the bulk counter-ions 
in the solution [186, 187]. This region is called the diffuse layer, and the whole system 
called an electrical double layer [188]. (see Fig. 3.2) 
 
Fig. 3.2 The relationship of the electric potential and the distance from the particle surface [189]. 
 
When a voltage is applied to the solution in which particles are dispersed, particles will 
be attracted by the electrode of the opposite polarity, and they will move to the 
electrode accompanied by the fixed layer of ions whilst the diffuse double layer 
consisting of oppositely charged ions moves to the opposite electrode. The term 
zeta-potential refers the electrical potential at the plane of shear between the particle 
and diffuse layer. It needs to be noted that zeta-potential is not equal to the potential of 
the stern layer [190] or particle surface [188]. The zeta-potential may be calculated 
from the Smoluchowski equation [186] (Equation 3.1).  
Equation 3.1                    ζ=uη/ε 
Where u is the mobility of the particle, η is the viscosity of the solution and ε is the 
permittivity of the solution, respectively. 
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In this work, zeta-potential measurements were used to track the deposition process of 
the polyelectrolytes. With the change of the zeta-potential, one can determine whether 
the polyelectrolyte has adsorbed on the particles. For example, as Fig. 3.3 shows, the 
polystyrene (PS) particles are negatively charged. When the first layer (chitosan) 
adsorbed on the particle, the zeta-potential of the coated particle turns positive. Then 
the second layer (sodium alginate) formed, and the zeta-potential switched to negative. 
Repeating the cycle, we observe positive zeta-potential for the odd layer, and negative 
potential for the even layer. Each time of the change of the zeta-potential (from positive 
to negative and vice versa) confirms each polyelectrolyte layer’s deposition. 
 
Fig. 3.3 Graph of zeta-potential of CHI and ALG depositing on PS particles [113] 
 
The instrument used in this project to measure the zeta-potential of was the Zeta 
Potential Utilizing Phase Analysis Light Scattering (ZetaPALs) from the Brookhaven 
Instruments Corporation (Fig. 3.4). The general procedure for determining the 
zeta-potential of a sample is as follows: 
 First, the measuring electrode was rinsed with deionised water and air dried.  
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 Then 1.5 ml of the sample was put into the measuring cuvette and the 
air-dried electrode was tightly plugged into the cuvette. The 1.5 ml liquid 
could totally cover the surface of the electrode.  
 Afterwards, the whole system (the cuvette and the electrode were carefully 
put into the measuring slot inside the machine).  
 All the measuring conditions were set to the default condition and if there 
was no specific situation, the measuring medium was chosen as water. Each 
measuring cycle lasts for about one minute 5 cycles were recorded for each 
measurement, the zeta-potential then being taken as the average of these five 
measurements.  
 Each Layer-by-Layer adsorption process was duplicated in this project and 
thus the zeta-potential of each layer was measured twice to see whether the 
two results shared same trends and had similar value (Same trend means the 
two results were both positive or negative and similar value means that there 
was no big variance (within ±10 mV). If there were large variations then the 
experiment was repeated a further time). For all zeta-potential measurements, 
no added electrolyte was required as the adsorption process occurred in 
moderately concentrated sodium chloride solutions (typically 0.1 mol/L). 
 
Fig. 3.4 The machine (ZetaPALs) used to measure the Zeta-potential of the nanoparticles 
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To make the measurement process clearer, a typical example of the zeta-potential 
results is given in Table 3.1 and Table 3.2 for two independent experiments for the 
adsorption of chitosan and dextran sulphate onto 95 nm silica particles.  
Table 3.1 The zeta-potential of each polyelectrolyte layer coated on 95 nm silica particles (CHI/DS 
0.1 M NaCl) (First measurement) 
 Number of Layers Zeta-potential (mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
-38±3 
+28±4 
-32±3 
+58±5 
-26±2 
+51±4 
-30±3 
+53±5 
-25±3 
+56±4 
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Table 3.2 The zeta-potential of each polyelectrolyte layer coated on 95 nm silica particles (CHI/DS 
0.1 M NaCl) (Second measurement) 
 Number of Layers Zeta-potential (mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
-34±4 
+29±1 
-37±3 
+57±3 
-30±4 
+53±2 
-28±2 
+51±5 
-29±2 
+50±3 
 
In tables 3.1 and 3.2, it can be clearly seen that considering the standard error, the 
zeta-potential measurements of each polyelectrolyte layer lies in the variation zone 
(±10 mV) that we set before the experiment. Therefore, the result of the first 
experiment was taken and reported. All the zeta-potential measurements followed this 
standard process.  
 
3.2 Dynamic Light Scattering 
Dynamic light scattering (DLS) (also known as Quasi-elastic Light Scattering, or 
Photon Correlation Spectroscopy) is a technique used to measure the size and size 
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distribution of small particles in suspension or polymers in solution [191-193]. The 
advantages of the DLS measurement are obvious, such as short measuring duration, 
automatic measurement and no extensive experience needed. Thus, DLS as a routine 
measurement of particle size distribution is now being widely used [194].  
 
The basic principle of DLS is described as below: When a small particle is hit by light, 
as long as the particle is small enough compared with the wavelength of light, the light 
would scatter in all directions. When the light source turns to a laser which is coherent 
and monochromatic, a time-dependent fluctuation could be observed in the scattering 
intensity [195]. These fluctuations are caused by the Brownian motion of the small 
particle/molecule in solutions. Also the intensity of the fluctuation is at a rate affected 
by the particle size, as smaller particles in the same time span would move farther and 
faster. The dynamic information (e.g. the diffusion coefficient) could be derived from 
the autocorrelation of the intensity records [196] and with the Stokes–Einstein equation 
[197] (Equation 3.2), the particle size may be calculated [195, 198]. The particle size 
obtained here is called hydrodynamic diameter, because the size from this technique 
not only includes the exact size of the particles but also any structure attached to the 
particles [191]. 
 
Equation 3.2             Dh=
   
    
 
Where Dh is the hydrodynamic diameter of the particles; T is the temperature in Kelvin 
degree (in this thesis, it was set as 298 K); kB is the Boltzmann constant; η is the 
viscosity of the medium; D is the diffusion coefficient [195]. 
 
The instrument used in this project was the 90Plus Size Analyzer from Brookhaven 
Instruments. Before the test, 0.05 ml of the sample was diluted with deionised water to 
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a total volume of 0.5 ml. Then, 0.1 ml of the diluted sample was added into a 3 ml 
acrylic square cuvette, and then the total volume made up by deionised water to 2.5 ml. 
The cuvette was then placed into the instrument to measure the size distribution of the 
nanoparticles. As it was the case for the zeta-potential measurement, all the measuring 
conditions were set as default and generally the measuring medium was chosen as 
water. Each measuring cycle lasts for about one minute and five cycles were recorded 
for each measurement and the particle size was taken as the average of five readings. 
Each sample was tested twice and if there was no obvious difference (less than 5%) 
between the two tests, the result from the first measurement was selected as the average 
particle size. 
 
3.3 Electron Microscope 
Electron microscopes (EM) are scientific instruments that use a beam of highly 
energetic electrons to examine objects on a very fine scale [199]. Due to the big 
difference of the wavelength between electron and visible light, the EM, compared with 
optical microscopes, has much higher resolution (down to 50 pm [200]) and much 
greater magnification (up to 10
7
) [201]. Therefore, electron microscopes are widely 
used to observe biological, organic and inorganic samples. There are several types of 
electron microscopes, including scanning electron microscope (SEM), reflection 
electron microscope (REM), transmission electron microscope (TEM), scanning 
transmission electron microscope (STEM), low-voltage electron microscope (LVEM) 
et al [199]. In this thesis, SEM and TEM were the two main characterisation methods to 
observe the nanocapsules obtained from the experiments. In the following paragraphs, 
details of these two methods including theory and sample preparation are discussed. 
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3.3.1 Scanning Electron Microscope 
The scanning electron microscope (SEM) is a type of electron microscope utilising the 
interaction of emitted electrons and atoms of a sample to collect information of the 
topography and other properties of the samples surface [202]. Due to the manner in 
which the image is created, SEM images have a characteristic appearance and are 
useful for judging the surface structure and topology of the sample [199, 203]. Fig. 3.5 
shows the general inner structure of an SEM. 
 
In a typical SEM firstly, electrons are thermionically emitted and are accelerated 
towards an anode. The electrons can be emitted either, from a metallic cathode 
(tungsten or lanthanum hexaboride LaB6) or, via field emission. After being focused by 
a series of (magnetic) lenses and passing through pairs of scanning coils which makes 
the beam raster scan over the sample. When the electron beam strikes the surface of the 
sample, the primary electron beam effectively spreads and interacts with the sample 
and fills a teardrop-shaped volume, known as the interaction volume, extending 100 nm 
to 5 μm depths into the surface. Interactions in this region lead to the subsequent 
emission of electrons which are then detected by special detectors to produce an image 
of the sample surface and displayed on a computer monitor [204, 205]. 
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Fig. 3.5 Graph of the inner structure of a SEM [206] 
 
In this projest, a LEO Gemini 1525 SEM (shown in Fig. 3.6) was used to analyse the 
nanoparticles coated with polyelectrolytes and hollow capsules derived from the core 
removal process. The samples for SEM test were prepared as followings. 
 Firstly, the samples of coated particles were diluted approximately 10 times 
with deionised water; the hollow capsule samples were used as they were after 
the core removal process.  
 The samples were then dropped onto the pre-polished SEM aluminium stub and 
the drops were dried in a petri dish at room temperature for at least 24 hrs.  
 The dried samples were coated with a layer of gold or chrome at the presence of 
argon in a special coating machine (Peltier Cooled High Resolution Sputter 
Coater K575X, EMITECH). This coated process lasted for one and half 
minutes.  
 The pre-coated samples were placed in the SEM and observed under electron 
beams from 1 kV to 5 kV. 
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Fig. 3.6 Leo 1525 Gemini Field Emission Gun SEM 
 
3.3.2 Transmission Electron Microscope 
Transmission electron microscope (TEM) is an imaging technique in which a beam of 
electrons interacts with a sample when it passes through and an image of the sample 
could be generated by the interactions [207, 208].  
 
The basic components of TEM are similar to those of SEM as both contain an electron 
gun, lens to focus the electron beam, and coils to deflect the beam. Only with a much 
more powerful electron gun and much thinner samples, the electron beam in a TEM can 
transmit through the sample, which makes a TEM works much like a slide projector. A 
projector shines a beam of light through (transmits) the slide (the specimen holder), as 
the light passes through, it is affected by the structures and objects on the slide. These 
effects result in only certain parts of the light beam being transmitted through certain 
parts of the slide. This transmitted beam is then projected onto the viewing screen, 
forming an enlarged image of the slide [207, 209]. 
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Fig. 3.7 Graph of working principle of TEM [210] 
For all the experiments in this thesis, the TEM machine used was a JEOL 2010 TEM 
(shown in Fig. 3.8), fitted with Oxford Instruments ISIS EDS (energy dispersive X-ray 
200kV) system. To prepare the samples for the TEM test, all the samples were diluted 
100 fold with deionised water and the diluted samples were dropped onto the TEM 
sample holder (200 mash copper grid form Agar Scientific Inc.). The samples were 
dried under an air drier at a temperature of around 35 
o
C.  
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Fig. 3.8 JEOL 2010 TEM 
 
3.4 Disc Centrifuge 
As a complementary method of particle size measurement, the Disc Centrifuge was 
used in this project to measure the size distribution of gold nanoparticles. The reason 
for using this technique was because it could measure nanoparticles as small as 2 nm, 
which is suitable for the size range of the gold nanoparticles prepared for 
functionalising the nanocapsules. The basic principle of the Disc Centrifuge is 
illustrated in Fig. 3.9.  
 
Fig. 3.9 Illustration of principle of the Disc Centrifuge [211] 
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As is shown in the Fig. 3.9, the particle suspension is injected into the centre of a 
rotating disc such that the particles move by a centrifugal force towards the outside of 
the disc. As it was described by Stokes (Stokes’ law), the velocity of the particles is in 
direct proportion to the square of the particles’ diameters [212, 213]. By the light beam 
shone through the disc, the velocities of all the particles is detected and the size 
distribution of the particles could also be deduced [214]. 
 
In this project, 0.05 ml gold nanoparticles suspension was injected directed into Disc 
Centrifuge after the preparation and the spin speed was set at the maximum of 20,000 
rpm. The sample was tested twice and the average of the two readings was taken. 
 
3.5 X-ray Powder Diffraction 
X-rays were discovered in 1895 by W. C. Röentgen and their wavelength is within the 
range of 0.1 to 10 nm. This range lies between gamma rays and UV rays [215]. There 
are many applications of X-rays, such as X-ray crystallography, X-ray radiography and 
X-ray fluorescence spectrometry [216]. In this thesis, the application of X-ray on 
crystallography will be discussed and X-ray powder diffraction (XRD) as a main 
technique in this category was employed in this project to characterise the magnetite 
particles prepared for functionalising the nanocapsules.  
 
X-ray powder diffraction is a technique used to identify and analyse crystalline 
materials, such as minerals, ceramics, and other chemical compounds [216] and it was 
independently discovered by Debye (1916), Scherrer (1917) and Hull (1917) [217]. 
Thus, it is widely used in geology, chemistry, material science and biology [218].      
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As Fig. 3.10 shows, there are 3 main parts of a diffractometer: the X-ray tube, the 
sample holder and the detector. The X-rays are generated by a cathode in the X-ray tube. 
The X-ray is then filtered and concentrated to obtain monochromatic radiation. When 
the incident X-ray shines on the sample, the ray will interact with the sample and if the 
conditions described by the Bragg’s Law (Equation 3.3) are met, the interaction would 
provide constructive interference and a diffracted ray is detected. Therefore, as can be 
seen in Fig. 3.10, following Bragg’s Law, if the angle between incident ray and the 
lattice surface is θ, then the angle between the diffracted ray and incident ray remains as 
2θ [219]. The detector in the diffractometer would move through a range (normally 5 to 
70 degrees) to collect all the possible 2θ diffraction information, due to the random 
orientation of the lattices [218]. Then all the information is recorded and a diffraction 
pattern is observed. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 
 
Fig. 3.10 The diagram of the principle of the X-ray powder diffractometer [216]  
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Equation 3.3             nλ=2dsinθ 
Where n is an integer, λ is the wavelength of the incident X-ray, d is distance between 
the atom layers in the lattice, θ is the angle between incident ray and the lattice surface.  
 
Because each material has its unique arrangement of atoms, each material produces a 
unique diffraction pattern. The structure of the crystal can be calculated and refined a 
priori, but generally is obtained by comparing the pattern with the standard pattern data 
bases, such as the Cambridge Structural Database (CSD) or the International Centre for 
Diffraction Data’s Powder Diffraction File (ICDD-PDF) [219]. Generally, the 
diffraction patterns for crystalline materials present a series sharp peaks whereas 
broader peaks could be observed for amorphous materials [219]. 
 
The crystallite domains of the materials could be calculated [220] from the Sherrer 
equation (Equation 3.4) , and when this domain is less than 100 nm, it corresponds 
approximately to the actual average size of the particles [221]. Therefore, XRD data 
could be used to estimate the average size of nanoparticles. In this thesis, the mean size 
of magnetite nanoparticles was calculated by the XRD diffraction pattern of the 
particles [222] and the size distribution of the nanoparticles was further confirmed by 
TEM. 
 
Equation 3.4      τ=Kλ/(βcosθ) 
Where τ is the size of the crystalline domain; λ is the wavelength of the X-ray; β is the 
width at half maximum intensity of the peak; θ is the angle between incident ray and the 
lattice surface [223]; K is a shape factor which for magnetite, is normally set as 0.9 
[222]. 
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For this experiment, due to the sample size being around 10 nm, no further grinding 
was needed. Therefore, the sample suspension was dried in the fume cupboard for 48 
hrs and 100 mg of the dried powder was placed into the sample holder as the specimen 
for the XRD analysis. The X-ray diffractometer used was a Philips PW1700 instrument 
(Fig. 3.11) which was operated at 40 kV and 40 mA. The diffraction pattern was 
compared with the database of ICDD-PDF. 
 
Fig. 3.11 The Philips PW1700 X-ray diffractometer 
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Chapter 4 Nanocapsules Based on Silica 
Core Templates 
4.1 Materials 
The core template used in this section was silica nanoparticles which were prepared in 
our laboratory; the methodology will be discussed in the following section. The 
biodegradable polysaccharides were cationic chitosan of low molecular weight and 
anionic dextran sulphate. Chitosan (CHI) (50,000-190,000 Da, 75-85% deacetylated, 
pKa 6-7) was purchased from Sigma-Aldrich and Dextran sulphate (DS) sodium salt 
from Leuconostoc spp. (approximate 10,000 Da) was obtained from Sigma-Aldrich. 
Other chemicals involved in this experiment include: Ethanol (CH3CH2OH, 96% v/v, 
BDH), Ammonium Hydroxide Solution (NH4OH, 28-30% NH3 content, 
Sigma-Aldrich), Tetraethylorthosilicate (Si(OC2H5)4 or TEOS, 98%, Sigma-Aldrich), 
Sodium Chloride (≥ 99.5%, Sigma). Hydrofluoric acid and Ammonium fluoride, used 
in the core removal process were obtained from Aldrich. The Visking dialysis tubing 
(diameter 38.1 mm, MWCO-12-14000 Da) used here was obtained from the Medicell 
International Ltd. All water used in the experiment was deionised. All the materials 
used in this experiment were used without further purification. 
 
Safety note: During the core removal process, HF was used. Because HF is highly 
toxic, the core removal process was carried out in a fume cupboard. Double layer 
gloves and safety goggles were worn and another person was asked to stand by during 
the process in case of any emergency. 
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4.2 Methodology 
4.2.1 Synthesis of Silica Nanoparticles 
There are two important advantages of using silica nanoparticles as a core material to 
prepare biocompatible nanocapsules. The first one is the size of the particles. By using 
different methods, the particle size could be confined within the range between 96 nm 
to 250 nm. As it was mentioned in the literature review, there are many advantages to 
use nano-scale drug delivery system, so the size range is a key point of the whole 
project. The second advantage is that as an inorganic template, the silica cores could be 
removed completely by etching with HF and there is barely any core material residue 
left in those capsules.  
 
To prepare the silica nanoparticles, the method first introduced by Werner Stöber et al. 
[224] was used in this work. First, 1.6 ml of NH4OH and 50 ml of ethanol were 
thoroughly mixed together, and then 4 ml of TEOS was added into the solution. 
Initially the reaction time was varied (between 4-24 hr). However it was determined 
that at least 8 hr was required to produce mono-modal dispersions (see section 4.3.1.1). 
Thus, in this experiment, the system was left in the fume cupboard and stirred at a speed 
of 300 rpm overnight. NH4OH is a catalyst in this system, and the amount of NH4OH 
will affect the size of the silica particles. So in this experiment the amount of TEOS and 
Ethanol were fixed and 1.4 ml 1.6 ml, 2.0 ml, 2.4 ml, 2.8 ml and 3.2 ml of NH4OH were 
employed to make the silica particles ranging from 96 nm to 250 nm. 
 
After the reaction ended, the whole solution was transferred into the dialysis tubing 
(both ends were tied up) and dialysed against deionised water (2 L in a beaker) for at 
least two weeks, during which the deionised water was changed at least once every day 
(see Fig. 4.1). After the dialysis, the total volume of the particle suspension was slightly 
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different from the original one (due to the empty space left during the tying of the 
dialysis tubing) and the volume was about 5-10% (by estimation) larger than the 
original volume. Therefore, the concentrations of the silica nanoparticles were 
measured and calculated after the dialysis process. 
 
 
Fig. 4.1 Diagram of the dialysis process 
 
After dialysis, the silica suspensions were collected from the dialysis tubes and stored 
in wide neck glass bottles. 10 ml of the silica particles prepared from the methods (1.4 
ml NH4OH/4 ml TEOS, 1.6 ml NH4OH/4 ml TEOS, 1.8 ml NH4OH/4 ml TEOS) were 
dried in the oven at a temperature of 100℃ for 48 hr to measure the weight percent of 
the silica suspensions. The weight percent of all three suspensions was close to 1.2% 
(the weight of silica nanoparticles versus the weight of the particle suspension), 
compared to a theoretical weight percentage of the silica particles of around 2.3%. 
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4.2.2 Polyelectrolyte Preparation Process 
Both the low molecular weight Chitosan (CHI) and Dextran sulphate sodium salt (DS) 
were dissolved in 0.1 M of NaCl solution at a concentration of 1 mg/ml; note that 
because of the screening effect, the concentration of NaCl will affect the electrical 
double layer thickness of each poly-electrolyte layer [113].. However, CHI could only 
be dissolved in acidic conditions so the CHI solution was also adjusted to pH 3 by HCl. 
The pH value of the DS solution was 6.5. All the measurements of the pH value in this 
thesis were carried out on a Fisher Accumet pH Meter 15 and each measurement was 
repeated to ensure the accuracy of the data (difference within 0.1).  
 
4.2.3 Layer-by-layer Self Assembly Process 
In this process, all of the materials including the silica particles and polyelectrolyte 
solution were prepared as described in the previous sections. Ionic polysaccharides 
were adsorbed onto the silica particle surface via the Layer-by-Layer method. Since the 
silica particles were negatively charged, the first layer of polyelectrolyte was CHI. The 
first layer was deposited with addition of 2 ml CHI solution (1 mg/ml) solution and 1 ml 
deionised water into 1 ml silica particles (1.2 wt%). The pH value of the mixture was 
determined to be 3.3, and it was incubated for 1 hr under gentle shaking. After that, the 
excess polymer was removed by two repeat cycles: centrifugation (3000 g, 4 min)/ 
re-dispersed in 2 ml of deionised water. The second layer followed the same procedure 
of the first layer but DS replaced CHI. By repeating this process, 9 layers of 
polyelectrolyte were deposited on the silica particles. The deposition of each layer was 
monitored by zeta-potential measurements. 
 
Although in this process no accurate determination of the excess polyelectrolytes in the 
solution was made, the two centrifugation and re-dispersion cycles would 
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approximately remove more than 99% of the excess polyelectrolytes. Because after 
each centrifugation, the particle residue plus solution remaining would be no more than 
0.2 ml and that means in the two washing cycles the remaining 0.2 ml liquid from the 
original solution would be diluted 100 times. Since the original residue was 10% of the 
total amount, in that case after the centrifugation/re-dispersion process the final particle 
suspension only contained about 1% of the polyelectrolyte from the last layer, which 
could be ignored.  
 
4.2.4 Core Removal Process 
Hollow nanocapsules were prepared by dissolving the silica cores in the HF/ NH4F 
buffer solution (2 M HF/8 M NH4F), this process was performed in polycarbonate tubes 
as the HF would dissolve glass as well as silica. The coated particles were dissolved in 
the HF/ NH4F solution for 2 hr (volume ratio 1:1). Then, the solution was centrifuged at 
9400 g for 6 min. After that, the residual was rinsed, centrifuged and re-dispersed in 
water to thoroughly remove the buffer solution. 
 
Dissolving the silica core was simulated by dissolving silica particles directly. 1 ml of 
the HF/ NH4F buffer solution and 1 ml of silica particles were mixed together, and kept 
for 2 hr. The solution, which contains silicon ions was analysed by inductively coupled 
plasma - optical emission spectrometer (ICP-OES), to ensure dissolution. 
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4.3 Results and Discussions 
4.3.1 Sizes of Silica Particles 
4.3.1.1 The Reaction Time of TEOS Hydrolysis 
Judging from the final particles sizes distribution it was found that 8 hr is the minimum 
time for the TEOS hydrolysis reaction and that 20 hours was a more suitable time to 
allow the reaction to proceed. If the reaction ran for less than 8 hr, a bimodal 
particle-size was found, as is shown in the Fig. 4.2. 
 
 
Fig. 4.2 Particles size distribution of the silica particles from the method: 50 ml Ethanol 4 ml 
TEOS and 2.4 ml NH4OH with reaction time of 4 hr. 
 
From Fig. 4.2, it can be seen that as well as particles in the size range 100-300 nm, a 
batch of larger particles (around 10 vol% of the total amount) with a size diameter of 
round 1 m was prepared during the process as well. Compared with this dispersion, 
the particles made from the reaction which lasted overnight (at least 20 hr) produced a 
mono-dispersed distribution (Fig. 4.3). 
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Fig. 4.3 Particle size distribution of the silica particles with the method of 2.4 ml NH4OH. 
 
4.3.1.2 The Effect of the Catalyst (NH4OH) 
Ammonium hydroxide is the catalyst in this reaction and will affect the size of the silica 
particles [224]. Therefore in this experiment, different amounts of NH4OH were used to 
obtain different sizes of silica particles. In this experiment 6 different amounts of 
NH4OH were used to prepare silica nanoparticles with different sizes. The results are 
given in Table 4.1. 
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Table 4.1 Silica particles prepared with different amounts of NH4OH 
Amounts of NH4OH(ml/50 ml Ethanol) Particle sizes(nm) 
 1.4  
1.6 
2.0 
2.4 
2.8 
3.2 
96±14 
114±12 
154±10 
200±25 
224±34 
252±38 
 
As can be seen in Table 4.1, the effect of increasing the NH4OH concentration is to 
increase the particle size.  
 
4.3.1.3 SEM Results of Particles Derived from Different 
Methods 
After the measurement of all the size distributions of the silica particles, all the samples 
(few drops of each sample) were dried out on aluminium stubs and coated with a layer 
of chromium. SEM tests to see the morphological properties of the silica nanoparticles 
are shown in Fig. 4.4 - Fig. 4.8. 
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Fig. 4.4 SEM micrographs of the silica particles from the method: 1.4 ml NH4OH/4 ml TEOS 
 
 
Fig. 4.5 SEM micrographs of the silica particles from the method: 1.6 ml NH4OH/4 ml TEOS 
 
 
Fig. 4.6 SEM micrographs of the silica particles from the method: 2.4 ml NH4OH/4 ml TEOS 
 
 74 
 
 
Fig. 4.7 SEM micrographs of the silica particles from the method: 2.8 ml NH4OH/4 ml TEOS 
 
 
Fig. 4.8 SEM micrographs of the silica particles from the method: 3.2 ml NH4OH/4 ml TEOS 
 
From the above figures, the shape and size distributions of the silica particles are clearly 
demonstrated. From the micrographs, it can be seen that the silica particles are tightly 
arranged and formed multi-layer silica clusters. The fact that the particles appear to be 
in layers suggest s that the particles are not aggregated but formed these layers on 
drying. From the micrographs, it also could be seen that the higher the NH4OH 
concentration used the broader the size distribution of the silica particles. This situation 
might be because at high NH4OH concentration the TEOS/ethanol/NH4OH mixture 
was not stirred fast enough. However, due to the limitation of the experimental 
equipment, it was very hard to keep this system running at very high stirring speeds 
without any spillage. Because we are trying to build a therapeutic delivery system into 
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the human body, as it was mentioned in the literature, particles of smaller size would be 
preferred, therefore, silica particles (from the methods: 1.4, 1.6 ml NH4OH/4 ml TEOS) 
were adopted as core templates for the polyelectrolyte self-assembly experiments.  
 
4.3.2 Polyelectrolyte Assembly Process 
4.3.2.1 Salt Concentration in Polyelectrolyte Solution 
Different salt concentrations were used in this experiment to analyse the affect of salt 
concentration on each polymer layer. Four salt concentrations: 0.5 M, 0.3 M, 0.1 M, 
0.01 M NaCl were used in these experiments, and the rest of the method kept the same. 
The difference for each layer deposited under different salt concentrations could also be 
monitored by zeta-potential measurement and the results are shown in Table 4.2. 
Table 4.2 Zeta-potential of the 1st layer under different NaCl concentration 
 Salt concentration Zeta-potential of the 1st layer(mV) 
 0.5 M  
0.3M 
0.1M 
0.01M 
+21±3 
+23±3 
+28±4 
+35±5 
         
The data in Table 4.2 shows that the higher the salt concentration, the lower the layer 
zeta-potential. That is mainly because the ions from the salt will screen the charges on 
the layer surface. So that is why with higher salt concentration, the thickness of the 
polyelectrolyte layers is larger [225]. However, in this experiment, 0.1 M NaCl was 
chosen as the salt concentration for the polyelectrolyte solution. That is because after 
deposition, it was found very hard to re-disperse the samples at salt concentrations of 
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0.3 M and 0.5 M and some aggregation was observed at the bottom of the centrifuge 
tubes (see Fig. 4.9); for a sodium chloride concentration of 0.01 M, the polyelectrolyte 
layers formed at this concentration would probably be too thin, which would reduce the 
strength of the nanocapsules. Therefore a concentration of 0.1 M NaCl was used. 
 
Fig. 4.9 The first layer (CHI) deposition at different salt concentration (from left to right 0.1 M, 0.3 
M, 0.5 M) 
 
4.3.2.2 Deposition Time 
The time for polyelectrolyte layer deposition was also investigated. The times: 15 min, 
30 min, 1hr and overnight were evaluated. The results of the zeta-potential of the 1
st
 
layer deposition at different deposition time are shown in Table 4.3. All the depositions 
were carried out at conditions of particle suspension: de-ionised water: polyelectrolyte 
solution 1:1:2 and a salt concentration is 0.1 M. 
 
 
 
0.5M 0.3M 0.1M 
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Table 4.3 The zeta-potential of the 1
st
 polyelectrolyte layer at different deposition time span 
 Deposition Time Zeta-potential of the 1st layer(mV) 
15min 
30min 
1hr 
Over 12hr 
+26±3 
+24±3 
+28±3 
+31±4 
From Table 4.3, within error (around 3 mV) no obvious difference could be observed in 
the 4 zeta-potentials. All the values would be sufficient for the next polyelectrolyte 
layer deposition. Therefore, in this experiment 1hr was used as the deposition time for 
each polyelectrolyte layer. 
 
All the deposition time and salt concentration tests were carried out on silica cores (95 
nm). Because the size difference is within 20 nm and zeta-potential difference is within 
10 mV, these conditions were also applied for the silica particles of 114 nm. 
 
4.3.2.3 Layer-by-layer Self-assembly Process 
Silica particles with a size of 95 nm and 114 nm were used as core templates in this 
experiment and 9 layers of biocompatible polyelectrolyte layers were coated onto the 
two samples. The zeta-potential of each deposition layer was measured to monitor the 
status of each deposition. The zeta-potential results are shown in Fig. 4.10 and Fig. 4.11 
(The values of the zeta potential are listed in appendix Table A.1 and Table A.2 
respectively). 
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Fig. 4.10 The zeta-potential of each polyelectrolyte layer coated on 95 nm silica particles (CHI/DS) 
 
 
Fig. 4.11 The zeta-potential of each polyelectrolyte layer coated on 114 nm silica particles 
(CHI/DS) 
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From both graphs, the shift of the zeta-potential negative/positive/negative confirmed 
the deposition of each layer. The zeta-potential of the bare silica is around -40 mV and 
for the layers of CHI and DS, it lies between 40 to 60 mV (except the first layer) and -30 
to -50 mV respectively. It can be seen in both Fig. 4.10 and Fig. 4.11 that the 
zeta-potential of the first layer is lower than the other odd layers. The reason for this 
situation is likely to be the level of adsorption of the first layer is slightly less than the 
other layers, as the first layer the chitosan adsorbs onto the sluice directly, whilst in all 
other cases the chitosan adsorbs onto the dextran sulphate layers.  
 
After coated 9-layer polyelectrolytes, the coated silica samples were also examined 
using the SEM tests (Fig. 4.12, Fig. 4.13) to compare with bare nanoparticles. 
 
 
Fig. 4.12 SEM micrograph of silica nanoparticles 95 nm (from 1.4 ml NH4OH/4 ml TEOS system) 
coated with 9 layers polyelectrolyte with a sequence: CHI/DS/CHI. 
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Fig. 4.13 SEM micrograph of silica nanoparticles 114 nm (from 1.6 ml NH4OH/4 ml TEOS system) 
coated with 9 layers polyelectrolyte with a sequence: CHI/DS/CHI. 
 
From Fig. 4.12 and Fig. 4.13, it is clearly seen the difference between the original (Fig. 
4.4, Fig. 4.5) and the 9-layer coated silica nanoparticles. After 9-layer coating, Instead 
of being smooth, the surface of the particles became fluffy, this is likely to be due to the 
adsorbed polyelectrolyte layers.   
 
4.3.3 Core Removal Process 
To obtain the hollow capsules, the core materials should be removed after the 
fabrication of the nanocapsules. Since silica particles could be dissolved in HF, an HF/ 
NH4F (2 M/8 M) buffer solution was adopted to try to control the dissolution process. 
Because for each layer deposition, some silica particles will be lost during the 
centrifugation process, it is hard to analyze the silica dissolving after the silica cores 
dissolved. Therefore, a simulation of dissolving the silica particles was employed to 
ensure the correct dissolution conditions were adopted. The original silica particle 
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solution contains 1.196 wt% of silica particles. The density of the solution is 1000 
kg/m
3
, so 1g of the solution contains 0.01196 g silica particles. The silica suspension
was mixed with 1 ml HF/NH4F buffer solution and the solution was kept in the fume 
cupboard for 2 hr. After dissolution, the mixture was diluted 10000 times and analysed 
in the ICP-OES. The data showed that over 90% of the silica (more than 90% of the 
silica present as an ion type in the solution) was dissolved. Therefore this condition was 
used to dissolve the core templates from the nanocapsules, the nanocapsules were then 
recovered and observed with both an SEM and TEM. 
Fig. 4.14 SEM micrograph of nanocapsules consisted of CHI and DS, based on silica nanoparticles 
95 nm (from 1.4 ml NH4OH/4 ml TEOS system) 
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Fig. 4.15 TEM micrograph of nanocapsules consisted of CHI and DS, based on silica nanoparticles 
95 nm (from 1.4 ml NH4OH/4 ml TEOS system) 
Fig. 4.16 SEM micrograph of nanocapsules consisted of CHI and DS, based on silica nanoparticles 
114 nm (from 1.6 ml NH4OH/4 ml TEOS system) 
Nanocapsules
Polymer residue 
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Fig. 4.17 TEM micrograph of nanocapsules consisted of CHI and DS, based on silica nanoparticles 
114 nm (from 1.6 ml NH4OH/4 ml TEOS system) 
From Fig. 4.14 and Fig. 4.16, the particles cluster after the core removal process can be 
observed. Compared with Fig. 4.12 and Fig. 4.13, the nanocapsules arrayed in Fig. 4.14 
and Fig. 4.16 appear aggregated. This may be due to the collapsing of some of the 
nanocapsules during the core removal process, and those polymer residuals attached to 
the rest nanocapsules to form the clusters in the SEM micrographs. The structure of 
polymer residuals attaching to the nanocapsules can also be seen in Fig. 4.15 and Fig. 
4.17. From Fig. 4.15 and Fig. 4.17, many collapsed nanocapsules were found. Some of 
them aggregated together and formed a very thick layer of polyelectrolytes (the dark 
areas in both graphs), whereas the others formed very thin layer (probably single or 
double layers) of polyelectrolytes (the grey amorphous areas in both graphs). There are 
also some grey spherical areas in both pictures and they have similar contrast as the thin 
amorphous polyelectrolyte layer, which indicates they are also only composed of 
polyelectrolytes. The spherical shape and the contrast demonstrate that those spherical 
grey areas are intact hollow capsules (spotted in Fig. 4.15, Fig. 4.17). In Fig. 4.15 and 
Fig. 4.17, it can be observed that, except the ones at the edge of the dark area, which is 
the polymer residue, there are also many nanocapsules lying under the polymer residue. 
Nanocapsules
Polymer 
residue
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Thus nanocapsules can be prepared by this method. However, because the HF is a very 
strong acid, many nanocapsules were broken during the core-removal process. It was 
very hard to separate the collapsed nanocapsules from the intact ones, so this result 
might not meet our needs for the further research. In addition HF is a dangerous acid 
and if such capsules are being contemplated for medical usage the use of HF is, to say 
the least, questionable. Therefore in the next Chapter the results for nanocapsules 
prepared using organic core templates will be presented and discussed.  
4.4 Conclusion 
In this Chapter the process of preparing nanocapsules derived from silica nanoparticles 
(size of 95 nm and 114 nm) was discussed. Silica nanoparticles were obtained via the 
hydrolysis of the alkoxysilane (TEOS) in a saturated alcoholic ammonia solution. In the 
reaction, the NH4OH was the catalyst and the amount of NH4OH confined the size of 
the silica nanoparticles. In this experiment, silica nanoparticles sizing from 95 nm to 
250 nm were prepared by varying the amount of NH4OH. Because the system was 
designed for drug delivery, two types of silica nanoparticles (95 nm and 114 nm) were 
chosen as the core templates and the Layer-by-Layer self-assembly method was applied 
to the silica cores with two oppositely charged polyelectrolytes: Chitosan and Dextran 
sulphate. The proper deposition time and salt concentration in the polyelectrolyte 
solution were also discussed. After the LbL process, the core-shell structures 
comprised of silica core templates and 9 layers of polyelectrolyte were finally obtained. 
Eventually, these two batches of coated silica nanoparticles were dissolved in the 
HF/NH4F buffer solution and nanocapsules were acquired from both batches. However, 
due to the strong erosion of the HF, some of the nanocapsules collapsed during the core 
removal process, the productivity was relatively lower than expectation. This might be 
due to the very small size of the core templates can result in thin and weak nanocapsules 
which could not survive from the erosion. Also the extreme toxicity of the HF could be 
a serious problem when applying the nanocapsules for drug delivery purpose. 
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Therefore, in the following Chapters, a new core template: polystyrene nanoparticles, 
was employed.   
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Chapter 5 Nanocapsules Based on Large 
Polystyrene Core Templates 
5.1 Materials 
The chemicals involved in this experiment were: Styrene monomer (99%, Sigma 
Aldrich), potassium persulphate (Sigma Aldrich), poly(sodium 4-styrenesulfonate) 
(PSS) (70000 Da, Sigma Aldrich), Poly (diallydimethylammonium chloride) 
(PDADMAC) (20 wt% in water, 100,000-200,000 Da, Sigma-Aldrich) and Sodium 
Chloride (99.5% Sigma Aldrich), Chitosan (CHI) (50,000-190,000Da, 75-85% 
deacetylated, pKa 6-7), Dextran Sulfate Sodium Salt (DS) (approximate 10,000 Da, 
from Sigma-Aldrich), Laponite (Rockwood additives), Tetrahydrofuran (THF, ≥99%, 
Aldrich). All water used was deionised. Two Visking dialysis tubings (diameter 38.1 
mm and 6.3 mm, MWCO-12-14000 Daltons) used here were obtained from the 
Medicell International Ltd. 
Because of safety considerations, all the experiments which employed styrene 
monomer in this thesis were carried out in fume cupboard. For the operators, safety 
goggles and double layer gloves were worn and a colleague was asked to stand by in 
the lab in case of any emergency.  
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5.2 Methodology 
5.2.1 Synthesis of Polystyrene Nanoparticles 
The polymerization of styrene, to prepare mono-dispersed polystyrene particles 
followed the method described by Goodwin et al. [226-228]. The experimental 
procedure is described below. Initially, because there is 10-15 ppm of inhibitor 4-tert 
butylcatechol (an inhibitor for the polymerisation of styrene) contained in the styrene 
supplied, the inhibitor was removed by flushing the styrene monomer at atmospheric 
pressure through an inhibitor removal column (obtained from Sigma-Aldrich 
Chemicals, Enzyme Commission Number 215-691-6, MDL number MFCD00081548) 
(Fig. 5.1). The styrene after this stage was kept in the fridge at 4°C for further use. The 
dispersion polymerisation took place in a 1L 3-neck round-bottom flask, an electric 
stirrer was placed in the middle inlet while the other 2 inlets were connected with a N2 
supply and a reflux condenser respectively (Fig. 5.2). 
Fig. 5.1 Inhibitor removal column 
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Fig. 5.2 3-neck Round-bottom reactor for polymerization 
The whole system was confined to 600 ml. Firstly 0.48 mol (55 ml) styrene monomer 
and 0.47 g NaCl were added via the middle inlet into the flask, in the meantime, the 
deionised water was also added to make a system total volume of 500 ml. The N2 valve 
was kept open when adding all the chemicals to quickly displace any oxygen from this 
system which would inhibit the polymerisation. The flask was immersed in a water bath 
set to 80 ℃. The stirrer was then fixed into the middle inlet of the flask and the solution 
was stirred at 350 rpm for 1hr to make sure all the reactants were properly mixed and to 
ensure the flask and its contents reached 80 ℃. Then 100 ml of an initiator solution (an 
aqueous potassium persulphate solution at a concentration of 1.332 10-2 mol/L) was
added into the system. The stirrer speed was maintained at 350 rpm for a further 2 hr 
and then reduced to 130 rpm. Also after 2 hours the N2 flow rate was reduced to a 
minimum to reduce any water evaporation from the flask. Finally the whole system was 
wrapped up with foil to minimise any water evaporation from the water bath which may 
occur overnight. The reaction lasted for 24 hr.  
After the reaction had finished, the clear solution had become milky. The polystyrene 
particle suspension was cooled down to room temperature and decanted through a 
funnel, which was loaded with glass wool to remove any large lumps of polystyrene 
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from the liquid. The filtered suspension was then dialysed to remove any unreacted 
styrene monomer, NaCl, initiator and surfactant. The dialysis lasted for 4 weeks, and 
fresh deionised water was changed every 24 hr. Due to the empty space left while tying 
the tube up process, the final volume of the particle suspension was slightly different 
from the original reaction volume, which could be 5-10% larger by estimation. After 
the dialysis, the particle suspension was tested and the concentration of the polystyrene 
nanoparticles was found to be 2.5 wt%. 
5.2.2 Layer-by-Layer Self-assembly Process 
5.2.2.1 Polyelectrolyte 
As well as the chitosan and dextran sulfate sodium salt, two other synthetic polymers 
were employed: negatively charged poly (sodium 4-styrenesulfonate) (PSS) and 
positively charged poly (dialyldimethyl ammonium chloride) (PDADMAC). Because 
polystyrene particles were negatively charged, PSS in the assembly process, acted as 
the even layers while PDADMAC as the odd layers. The PDADMAC and PSS solution 
contained: 1 mg/ml polyelectrolyte, 0.1 M NaCl; while the bio-compatible polymer 
solutions contained: 1 mg/ml polyelectrolyte and 0.1 M NaCl. However, chitosan, it 
could only be dissolved in an acidic condition, so the CHI solution also adjusted to pH 3 
by HCl. 
Laponite was used in this experiment as an alternative to a negative polyelectrolyte to 
strengthen the nanocapsules. Laponite is a synthetic silicate which resembles the 
natural smectite mineral hectorite, in both structure and composition [229]. Its 
molecular formula is    7.0 7.0
7.0
0.240.44.05.58 NaOHLiMgSi . 
The laponite particles were a 
commercial product obtained from Rockwood (Princeton, New Jersey), they are disk 
shaped (Fig. 5.3), approximately 25 nm in diameter and 1 nm thick. The disk itself is 
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strongly negatively charged on the flat face surfaces and has a weak positively 
charged on the edge (Fig. 5.3). 
Fig. 5.3 Geometry of Laponite disk [230]. 
In water, the laponite will exist as particle suspension. Under different salt and 
laponite concentration this suspension will demonstrate quite different properties (Fig. 
5.4) [231, 232]. 
Fig. 5.4 Phase Diagram of Laponite suspensions [232] 
F: Flocculation; IL: Isotropic Liquid; IG: Isotropic Gel; NG: Nematic Gel 
(●)rheological data, (○) osmometric data, (▲) birefringence data 
From Fig. 5.4, it can be seen that there are 4 distinct regions: F, where Flocculation 
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occurs; IL, where dispersion exist as an isotropic liquid; IG, where the dispersion 
exist as an isotropic gel; NG, where dispersion exist as a nematic gel. For the purpose 
of this research, it is clear that the laponite suspension should be kept within the IL 
region, in which the fluid exhibits Newtonian behaviour and the laponite disks are 
randomly dispersed in the suspension without any flocculation. In this experiment, the 
laponite particles (powder) were dispersed (by 2 min ultra-sonication) in deionised 
water and the concentration of the suspension was 10 mg/ml. 
5.2.2.2 Layer-by-Layer Self-assembly 
5.2.2.2.1 Nanocapsules Assembled with Synthetic Polyelectrolyte Only 
Initially, the polystyrene particles with size range around 480 nm were used as core 
templates. For the first layer, 10 ml of 1 mg/ml PDADMAC solution, which contains 
0.1 M NaCl, was added into the 5 ml polystyrene suspension (2.5%wt) with 10 ml 
deionised water. After 1 hr gentle shaking, the sample was centrifuged in an 
accuSpinTM 400 (obtained from Fisher Scientific).in a series of steps to separate the 
excess polymers from the coated particles: 3000 g for 5 minutes, 5472 g for 6 minutes, 
8425 g for 8 minutes, and 8425 g for another 13 minutes. The reason why several 
centrifugation steps were applied here was to gather the particles with different size 
ranges at different centrifugal forces, so that aggregation can be avoided; this ensured 
that the re-dispersion time was shorter and the effect was better than a one-step 
separation method where high speeds and long times were used.  
After centrifugation, all the particles were gathered and re-dispersed in 15 ml of 
deionised water. The re-dispersion was carried out in an ultra-sonic bath to break down 
the clusters of particles from the centrifugation by intensively shaking the suspension 
until the particle size fell down to 400-600 nm again. Such a cycle including 
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centrifugation/washing/re-dispersion was repeated 3 times for each coating layer. The 
deposition of subsequent PE layers was accomplished by repeating the same procedure. 
5.2.2.2.2 Nanocapsules Assembled with Polyelectrolyte and Laponite 
5.2.2.2.2.1 Synthetic Polyelectrolyte 
Following the same procedure mentioned in the last paragraph, 3 polyelectrolyte (PE) 
layers which consist of PDADMAC/PSS/PDADMAC were firstly deposited onto the 
particles.  After coating the polystyrene particles with 3 layers of PE layers, a layer of 
laponite followed by PDADMAC were added. However, it was found that the 
concentration of the particles was too high for the laponite deposition and the particles 
readily aggregated easily. Therefore, before coating with laponite, the polystyrene 
suspension was diluted 5 times to reduce the concentration to 20% of the original. 
Subsequent separation and re-dispersion cycle also followed the same manner as 
described above for PE layers. In this way one or more layers of laponite could be 
added into the walls of the nanocapsules. 
5.2.2.2.2.2 Bio-compatible Polyelectrolyte 
The nanocapsules based on the 480 nm polystyrene nanoparticles were also prepared 
with biocompatible polymers, CHI and DS. The deposition procedure of CHI and DS 
followed the one of PDADMAC layer; because polystyrene particles were negatively 
charged, the CHI was employed as odd layers while DS, on the even layers. 
There was one difference of the capsule preparation procedure between the bio- and 
synthetic- polymer, which refers to the laponite layers. Instead of putting several layers 
of laponite, only one layer of laponite was added as the outer layer after the deposition 
of the polymer layers.  
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5.2.3 Core Removal 
As an organic core template, polystyrene particles can be removed either by calcination 
or by dissolving in a solvent [1]. In this case however, because the capsule itself was 
made from organic material, the capsule wall cannot survive the very high temperature 
of the calcination, thus tetrahydrofuran (THF, ≥99%, Aldrich) was used to dissolve the 
polystyrene core (THF was used as it is a good solvent for polystyrene and is miscible 
in all proportions with water). Each of the coated particle suspensions was mixed with 
twice volume of pure THF, and the mixture was kept sealed in the fume cupboard for 
48 hr. After dissolution, in order to remove the THF and polystyrene residue, the 
solution was dialysed against de-ionised water. The solution of the mixture was moved 
to dialysis tubing (6.3 mm) and both ends of the tubing were then tied up. The loaded 
tubing was then placed into a beaker of 1 L deionised water and the water was changed 
every 12 hr for 7 days.  
5.3 Results and Discussion 
5.3.1. Polystyrene Core Particles 
5.3.1.1 Synthesis without Surfactant 
DLS using the 90Plus Size Analyzer determined the particle size distribution to be 
483±31 nm. Fig. 5.5 shows SEM micrographs of the particles which confirms this size. 
Fig. 5.5 also shows that the particles are largely mono dispersed, although there are 
some much smaller particles visible. A determination of the polystyrene weight 
percentage was also carried out. 10 ml of the polystyrene suspension was placed in a 
pre-dried Petri dish and kept in a high temperature oven for 48 hr. The weight of the 
aqueous suspension and the dried out residue were recorded as 2.5 wt%.  
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The zeta-potential of the surface of the core particle was also measured by the 
ZetaPALS. The result showed the zeta-potential of the polystyrene particles is -48±3 
mV. 
  (a)   (b) 
Fig. 5.5 SEM micrographs of the polystyrene particles with different magnifications 
5.3.2 Layer-by-Layer Self-assembly 
5.3.2.1 Parameters Affected the Experiment 
Parameters, such as the salt concentration, the deposition time, were tested and 
determined in order to optimize the LBL deposition process. In the following sections 
we will focus on the effect of these parameters. 
5.3.2.1.1 The Deposition Time 
For the synthetic polymers, the deposition time of the first layer of PDADMAC was 
examined, and the results are presented in Table 5.1. 
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Table 5.1 Zeta-potential of the particles after coating 1 mg/ml PDADMAC for different time 
Coating time 20 min 24 hr 72 hr 
Zeta-potential 
(mV) 
+46 2 +46 3 Aggregated 
The results showed that under gentle shaking for 20 min or 24 hr, there was no obvious 
change of the zeta-potential of the first polyelectrolyte layer. That indicated 20min or 
more is enough for finishing the polymer layer deposition. However, if this deposition 
lasted for too long, e.g. 72 hr (Table 5.1), some aggregation was found to occur in the 
particle suspension. That may be due to the extra polymer causing bridging flocculation 
or bare patch flocculation [1]. Subsequently, to make sure the polyelectrolyte 
deposition had finished and the polymer was properly arranged on the surface of the 
particles, 1 hr was chosen as the time allowed for PDADMAC deposition.  
For the bio-compatible polymers CHI + DS, the optimum time had already been 
determined on silica particles as 1hr. Therefore 1hr was also the time chosen for 
adsorption of CHI + DS onto polystyrene particles. 
5.3.2.1.2 Salt Concentration 
The NaCl concentration of the polyelectrolyte solution is also an important factor to 
affect the properties of each layer. As has been mentioned in the literature review, 
sodium chloride was introduced into the experiment to reduce the repulsion between 
polymer molecules. The sodium salt here acted as an agent to screen some of the 
charges on the surface of the polymer molecules, and decreased the repulsion between 
the same charged polymers. This effect would increase the polymer deposition and lead 
to thicker polymer layers. However, higher salt concentration would also result in a 
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lower zeta-potential of the coated particles. In this experiment, 3 different salt 
concentrations (0.0 M, 0.1 M and 0.5 M) were tested, based on polymer layers 
(PDADMAC/DS/PDADMAC) to determine the optimum salt concentration (Fig. 5.6). 
Fig. 5.6 Zeta-potential of the polymer layers (polystyrene/PDADMAC/DS/PDADMAC) at 
different salt concentration. 
The values are given in Appendix Table A.3. 
From Fig. 5.6, it can be clearly seen that there is an effect of salt concentration on the 
zeta-potential of the polymer layers.  For the same polymer layer, the value of the 
zeta-potential follows the order: 0.1 M>0.5 M>0 M; this phenomenon was much more 
obvious in the second layer which consisted of DS,  Therefore, 0.1 M Sodium 
Chloride was chosen to prepare the polyelectrolyte solution and conduct the adsorption 
experiments. 
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5.3.2.2 Preparation of the Nanocapsules 
5.3.2.2.1 Synthetic Polymers without Laponite 
5.3.2.2.1.1 Fabrication of the Nanocapsules 
Zeta-potential measurement was one way to determine each layer’s deposition during 
the preparation process. Fig. 5.7 shows the variation of the zeta-potential of each 
coating layer of the experiment of 5 bilayers of PDADMAC/PSS depositing onto PS 
particles (1 mg/ml PE and 0.1 M NaCl). Because each component was charged and the 
main interaction in this research was an electrostatic interaction, after each layer’s 
deposition, the zeta- potential shifts from the original to the opposite direction. In this 
graph, as expected, the zeta-potential varied between negative and positive, which 
confirmed the deposition of each sequential polyelectrolyte layer.  
Fig. 5.7 The zeta-potential of the each coating layer ((PDADAMAC/PSS)5 1 mg/ml PE, 0.1 M 
NaCl). 
 The value of each layer’s zeta-potential is given in the Appendix Table A.4. 
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From Fig. 5.7, it can be seen that the absolute values of zeta-potential of odd and even 
layers are larger than 40 mV, which meant that the deposition of each layer was 
complete and the coated particles were in a relatively stable state during each coating 
process. Also it can be found that the absolute value of the zeta-potential was tending to 
be smaller after each layer-coating. That explained why the coated particles 
occasionally became aggregated after around 12 layers. The coated particles were also 
examined under an SEM to monitor the coating and re-dispersion situation. 
Fig. 5.8 SEM micrograph of 10 layers (5 PDADMAC/PSS bi-layers) coated polystyrene particles 
It is clearly demonstrated in Fig. 5.8 that after coating with 10 layers of polymers, the 
coated particles were still well dispersed in the solution, and exhibited no obvious bulk 
aggregation. However, from Fig. 5.8, it can be observed that the particles were not as 
spherical as the original ones (Fig. 5.5) and there were some thread structures around 
the particles. The change of shape of the particles can be attributed to the fabrication of 
the 10 layers of polymers, and the thread materials is likely to be some residual 
polyelectrolyte dried from the solution.  
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In this project, laponite was also used as a capsule material to strengthen the capsules 
themselves. However, In order to create a particle surface with homogeneous charge 
density and to avoid ill-structured polyelectrolyte multilayer assembled, where the film 
roughness was too high compared with the film thickness [233], it was generally 
suggested that three layers of polyelectrolyte are required before the deposition of any 
inorganic nanoparticles such as silica and TiO2 [104]. As was mentioned in the 
methodology section, three layers of synthetic polyelectrolyte consisting of 
PDADMAC/PSS/PDADMAC were deposited before the laponite particles. The SEM 
micrographs of these pre-deposited particles are illustrated in Fig. 5.9.  
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(a) 
(b) 
Fig. 5.9 SEM micrographs of different magnifications of particles composed of 3 layers 
(PDADMAC/PSS/PDADMAC) 
From Fig. 5.9, it is clearly seen that compared with the original PS particles (Fig. 5.5), 
these three layers coated particles are more ‘fluffy’, but the whole surface of each single 
particle seems homogeneous, however, these particles still kept within the size range 
400-500 nm, as one may expect. 
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5.3.2.2.1.2 Core Removal 
After coating with 10 layers (5 PDADMAC/PSS bi-layers) of synthetic polymers, the 
coated particles were treated with THF to remove the core material (Fig. 5.10). 
(a) (b) 
      (c) 
. 
Fig. 5.10 TEM micrographs of the polystyrene particles with 10 layers after 24 hours of core 
removal 
From Fig. 5.10, the result of the core removal process to form nanocapsules can be seen. 
Fig. 5.10 a and b are micrographs of one single particle shown at different 
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magnifications. Fig. 5.10 b clearly shows the inner structure of this single capsule. By 
contrast, it can be clearly seen that the capsule itself has a wall about 10-15 nm thick 
and the hollow shell structure illustrated the successful removal of the polystyrene 
particle. Fig. 5.10 c is a cluster nanocapsules. There is a shadow area at the edge of the 
particle which stands in the middle of the micrograph. This shadow is likely to be 
formed by some polystyrene residues, however, the other particles compared with this 
one were relatively monotonic in colour, which illustrates that after the core-removal 
process, most of the polystyrene were removed from the hollow shell structure. 
However, it is clearly seen that the cluster of the particles were several nanocapsules 
overlapped together, and that some of the capsules were collapsed.  It is not clear 
whether the clustering was due to the capsules being flocculated or whether this 
clustering occurred during the drying of the capsules. The collapsing of the capsules 
suggests that the nanocapsules were not strong enough to survive as spherical capsules 
after core removal with THF. This is the main reason why laponite nanoparticles were 
introduced as a capsule material to prevent the collapsing of the walls of the capsules.  
5.3.2.2.2 Synthetic Polymers in Presence of Laponite 
5.3.2.2.2.1 The Precursor Polyelectrolyte Film 
As was described in section 5.3.2.2.1.1, the precursor particles (coated with 3 layers of 
polyelectrolyte) were prepared following the same deposition method used for the 
nanocapsules consisting of polyelectrolyte only. 
5.3.2.2.2.2 Fabrication of the Rest Layers (Laponite /PDADMAC) 
After the preparation of the polyelectrolyte precursor films, laponite and PDADMAC 
were added onto the polystyrene particles respectively. As Caruso et al. (1999) 
reported, 3 or 4 layers of polyelectrolyte precursors could not only make the particle 
surfaces uniformly charge to facilitate subsequent deposition of protein or other 
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alternative materials, but also can change the surface charge (from positive to 
negative and vice verse) for adsorption of some specific materials [170, 172]. 
Therefore, for the deposition of the laponite particles (inorganic nanoparticles), 3 
layers of PE were used as deposition precursor. Since laponite particles were 
negatively charged in the water solution, laponite was used to form the even layers 
while PDADMAC formed the odd layers. Fig. 5.11 demonstrated the SEM 
micrographs of the 8 (3 laponite layers) and 13 (5 laponite layers) layers coated 
polystyrene particles. 
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(a) 
(b) 
Fig. 5.11 SEM micrographs of the particles composed of (a) 8 coating layers (3 Laponite layers), (b) 
13 coating layers (5 Laponite layers) 
In Fig. 5.11, it was clear that the surfaces of the 8-layer (a) and 13-layer (b) coated 
particles are much rougher compared with polyelectrolyte coated ones (Fig. 5.9). 
Considering the shape of the laponite particles which is disk like, it was not surprising 
to find such a surface structure. However, there was no obvious difference between the 
8-layer sample and the 13-layer sample, which also indicated that the deposition of 
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Laponite particles introduced the roughness no matter what the outer layer was. From 
Fig. 5.11, it can be seen the size of 3, 8, and 13-layer sample was increasing steadily 
from 499 nm to 582 nm and finally reached to 604 nm, clearly demonstrating the 
deposition of polyelectrolyte and Laponite layers.  
Fig. 5.12 showed the shifting of the zeta-potential of each coating layer. As it was 
mentioned before, the shift of the zeta-potential confirms each layer’s deposition. 
Fig. 5.12 The zeta-potential of the each coating layer (synthetic polyelectrolyte and Laponite). 
The value of each layer’s zeta-potential is given in the Appendix Table A.5. 
From Fig. 5.12, the values of the zeta-potential can be divided by 2 parts. Part I is the 
region that only contained the 3 layers of precursor PE. The absolute values of these 
layers (above 40 mV) indicated a proper adsorption. In this part, the zeta-potential of 
the third layer (52.4 mV) was relatively higher than it of the first layer, which might be 
because of the reason explained in the section 5.3.2.2.1.1 and 5.3.2.2.2.2. At least 3 
layers of PE precursor can provide the particles with a uniformly charged surface [170, 
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172]. Also in Buron et al. and Dejeu et al.’s works [234, 235] indicated that it is 
necessary to employ some polyelectrolyte layers as a precursor before laponite or any 
other alternatives to polyelectrolytes. This precursor can on one hand provided a 
uniform and smooth surface for the further deposition, and on the other hand can 
enhance the zeta-potential of the exposed layer and made the next deposition more 
stable. 
Part II shows the process of the alternative deposition of the laponite and PDADMAC 
layer. Up to the 12th layer, all the zeta-potential were (above 40 mV) for the 
PDADMAC layers, which were very stable and very similar to the values of the first 
and third layers. However, compared with the PSS layers, the zeta-potential of the 
laponite layers were somewhat lower i.e. less negative (-30 mV). This difference was 
due to the structures of the PSS and Laponite. PSS was fully negatively charged 
molecules and Laponite was disk-shaped particle and was negatively charged on both 
flat surfaces and positively charged at the edge. Therefore, it was hard for 2 Laponite 
particles to pack as close as 2 PSS molecules on a polystyrene particle surface, and so 
the even layers after the 2
nd
 layer were more weakly charged. Also charge density of
laponite particles may be less. 
It is noticeable in the second region, after the 12
th
 layer, the values of the PDADMAC
layers were decreased (from 45 mV to 35 mV). This might due to the accumulation the 
laponite layers disrupted the smooth nature of the particles causing roughness and 
shifting the plane of shear of the zeta-potential from the particle surface. In that case, 
the PDADMAC layer may also not fully cover the surface, which reduced the absolute 
value of the zeta-potential, furthermore covered and uncovered areas of different 
particles would attracted each other and aggregation would occur as was seen after 18 
layers (7 layers of Laponite) coating (Fig. 5.13). 
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Fig. 5.13 SEM micrographs of the particles coated with 18 layers (PDADMAC/PSS/laponite) (10 
PE/8 laponite) 
5.3.2.2.2.3 Core Removal 
After the layer-by-layer self-assembly process, it was necessary to remove the PS cores. 
A solvent capable of dissolving PS and which is miscible with water is required. In this 
case, only THF and 1, 4-Dioxane met the requirement. Since THF is much cheaper, it 
was employed to remove the polystyrene nanoparticle core. Fig. 5.14 shows the TEM 
micrographs of before and after the THF treatment of the 5 layers coated polystyrene 
particles. 
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(a) (b) 
(c) (d) 
Fig. 5.14 TEM micrographs of nanocapsules consisting of 5 layers of polyelectrolyte and Laponite 
before (a,b) and after (c,d) the THF dissolving. 
The difference between the coated polystyrene particles and the hollow shells after the 
core removal process can be clearly seen in these transmission electron micrographs 
(TEM). In Fig. 5.14 a and b, the inner part is darker and represents the solid polystyrene 
particles and the bright part was the outer layers as here the material is thinner. After the 
core removal (c, d), the inner part was no long as dark as it was in micrographs a and b. 
Only a few dark particles can be seen in the micrographs, probably due to some 
un-removed polystyrene. This situation might be because the polystyrene particles are 
comprised of high molecular weight polymers which are hard to completely. 
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(a) (b) 
(c) (d) 
Fig. 5.15 TEM and SEM micrographs nanocapsules consisting of 8 layers (5PE/3Laponite) after 
the core removal process, (a) (b) SEM and (c) (d) TEM 
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Fig. 5.16 TEM micrographs of the nanocapsules consisting of 9 layers of polyelectrolyte and 
Laponite (6PE/3Laponite) after the core removal process 
 (a) (b) 
(c)  (d) 
Fig. 5.17 TEM micrographs of the nanocapsules consisting of 12 layers of polyelectrolyte and 
Laponite (7PE/5Laponite) after the core removal process 
111 
 (a) (b) 
(c) 
Fig. 5.18 TEM micrographs of nanocapsules consisting of 13 layers of polyelectrolyte and 
Laponite (8PE/5Laponite) after the core removal process 
Fig. 5.15-Fig. 5.18 show micrographs with different number of laponite layers (8, 9, 12 
and 13 layers). According to the micrographs, there is no obvious difference between 
the coated particles terminated with a laponite layer or the ones terminated with a 
polyelectrolyte layer. This suggests that the component of the outer layer would not 
affect the structure of the hollow capsules. Another phenomenon can be easily noticed 
from Fig. 5.15-Fig. 5.18 is that after the core removal treatment, some of the capsules 
collapsed and formed the “Cup-shape” structure. From the hollow and half-opened 
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structure, the removal of the polystyrene particles was confirmed. Beside the capsules, 
some polystyrene particles with much smaller size can be observed. The surface of 
these particles is smooth which seems there was not much PE or Laponite deposited. 
There may be two reasons for the appearance of these particles, one is the original 
particles just with smaller size (due to insufficient mixing, the particles did not have full 
exposure to the PE or laponite solution) and the other one is after core removal the 
polystyrene residuals escaped from the capsules. However, compared with Fig. 
5.15-Fig. 5.18, fewer particles (the smaller and smoother ones) are observed in Fig. 
5.14. During the core removal process, the solvent THF would diffuse through the 
preformed capsule walls and enter the inside of the nanocapsules. In this process, when 
accessed the THF the polystyrene particles would swell and become a little larger 
before dissolution. The swelling action of the polystyrene cores could deform the 
capsules attached to them. In Fig. 5.14, the capsules were consisting of only one 
Laponite layer, which makes the capsule themselves are more flexible than the ones in 
Fig. 5.15-Fig. 5.18 which contain more Laponite layers. In this case, during the 
swelling of the core templates, the more rigid capsules would possibly collapse more 
easily and the partially dissolved particles could easily escape to the solution. This also 
explained the phenomenon that much more cup-shaped hollow capsules were spotted in 
Fig. 5.15-Fig. 5.18 compared with Fig. 5.14. Also considering the Fig. 5.11, most of the 
particles presented the fluffy structure, so there was less opportunity for the appearance 
of the uncovered/incompletely covered polystyrene particles after the LbL coating 
process. Hence, in this case, the second explanation of the smaller and smoother 
particles seems more plausible.  
Overall, considering all the results and discussion in the core removal section, it may be 
concluded that the capsules without any laponite layers would be not strong enough to 
survival the core dissolving process, whereas, as for capsules consisting of several 
layers of laponite, the thickness and the strength can possibly be a barrier for the small 
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polystyrene particles to diffuse out of the capsules and led the capsule collapsed. So in 
the following experiments, only one layer of laponite was employed.  
5.3.2.2.3 Bio-compatible Polyelectrolyte 
5.3.2.2.3.1 Preparation of the Nanocapsules 
After the fabrication of the nano-capsules consisting of the bio-compatible polymers, 
10 layers (5 CHI/DS bi-layer) of polymer were deposited onto the polystyrene particles 
(Fig. 5.19). Then these particles were coated with another bi-layer (CHI/Laponite), 
which made the outer layer of these particles was Laponite (Fig. 5.20).  
(a) 
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(b) 
Fig. 5.19 SEM micrographs (at different magnification) of polystyrene particles coated with 10 
layers of biocompatible polymers 
(a) 
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  (b) 
Fig. 5.20 SEM micrographs of polystyrene particles coated with 11 layers of biocompatible 
polymers and one layer (outer layer) of Laponite particles, a) b) represent different 
magnifications 
From Fig. 5.19 and Fig. 5.20, it can be clearly seen that after the coating process, all 
the coated particles were well re-dispersed in the suspensions and all the particles 
shared similar appearance which confirmed all the particles were fairly coated. In Fig. 
5.20 the surface of the particles is rougher than it is in Fig. 5.19. This is because the 
outer layer in Fig. 5.20 is laponite while it is dextran sulphate in Fig. 5.19. Also it can 
be seen that in Fig. 5.19 there are some small lumps which might be capsule polymer 
residues attached to some particles, while in Fig. 5.20, they can be barely seen. That 
phenomenon illustrated that the laponite layer not only strengthened the capsules but 
also modify the shapes of the coated particles which might support the capsules 
surviving from the dissolving in THF. 
The deposition of the polymers was also confirmed by the zeta-potential measurement 
of each coating layer (Fig. 5.21).  
116 
Fig. 5.21 The zeta-potential of the each coating layer (biocompatible polymers and outer layer 
Laponite). 
The value of each layer’s zeta-potential is given in the Appendix Table A.6. 
Because the original particles and DS were negatively charged, and CHI was 
positively charged, the value of odd layers should stay positive while for the even 
layers the value should be negative. From Fig. 5.21, this point had been confirmed. 
Also from the trend of the zeta-potential, it can be noticed that the more layers coated 
onto the particles, the closer the zeta-potential was getting closer to zero. This might 
because there were mutual effects (electrical and steric) between different layers, and 
those effects can affect the outer layer to be thinner (compared with the former ones) 
or even not completely covered the whole particle surface, so the absolute value of the 
zeta-potential was becoming smaller. In that case, it was more complicated for further 
layer to deposit, and also the lower zeta-potential can result aggregation easily at 
some stage of the experiment like the centrifugal part. So this experiment, 10-12 
layers of biocompatible polymers would be a proper structure for the nano-capsules. It 
is also noticed that compared with the synthetic polymers the zeta-potential of the 
biocompatible polymer layers was relatively lower (-40 mV to +30 mV). This can be 
-60 
-40 
-20 
0 
20 
40 
0 2 4 6 8 10 12 14 
Ze
ta
-p
o
te
n
ta
l (
m
V
) 
Number of layers 
Zeta-potential of biocompatible polyelectrolyte (11L)  
and Laponite (1L) layers
0.1 M NaCl 
 117 
 
explained by the hardness of dissolving the CHI powder to make homogeneous 
solution. 
 
5.3.2.2.3.2 Core Removal 
After the preparation of the nanocapsules, the coated particles were treated with THF to 
dissolve the polystyrene core templates.  
(a)                                (b)       
 
Fig. 5.22 SEM micrographs of coated polystyrene particles after treated with THF. (a) coated 
with 10 layers(5 bi-layers CHI/DS); (b) coated with 12 layers (5 bi-layers CHI/DS plus bi-layer 
CHI/Laponite) 
 
The THF dissolving process was the same as that reported earlier, and the dissolution 
of the polystyrene particles was confirmed by the Fig. 5.10, Fig. 5.14- Fig. 5.18. 
Compare Fig. 5.22(a) and Fig. 5.22(b), it can be noticed that after dissolving of the 
polystyrene nanoparticles, the capsules with a layer of laponite survived more than 
those with only polymer layers. Also compared with the nanocapsules with several 
layers of laponite, the nanocapsules with only one layer of laponite were more likely 
to hold the shape and intact after dissolution in THF. 
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5.4 Conclusion 
In this Chapter, the fabrication of nanocapsules based on polystyrene nanoparticles 
(size around 480 nm) was discussed. Polystyrene nanoparticles were prepared via the 
polymerization of styrene monomers. The deposition time and salt concentration in 
the polyelectrolyte solution optimised and discussed. Nanocapsules of different 
composition were fabricated onto the polystyrene core-templates, including 
nanocapsules of polyelectrolyte, nanocapsules of polyelectrolyte and several layers of 
laponite and nanocapsules of polyelectrolyte and one layer of laponite. After the 
core-removal process, it was found the nanocapsules comprised of only 
polyelectrolyte were collapsed, due to the insufficient strength of the nanocapsules 
and nanocapsules of several laponite layers were also collapsed and formed some 
bowl-shaped hollow capsules, which might because the wall of the capsules is too 
thick. Finally, the nanocapsules comprised of one layer Laponite and polyelectrolyte 
was found to be the most regular, such as those nanocapsules consisting of 5 CHI/DS 
bi-layers plus one CHI/Laponite bi-layer were obtained after the core-removal 
process.   
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Chapter 6 Nanocapsules Based on Small 
Polystyrene Core Templates 
In Chapter 5, the preparation of nanocapsules based on submicron polystyrene 
particles has been discussed, however, due to the size issue we had discussed in the 
literature review that nanocapsules which are smaller than 200 nm would be 
preferable for the therapeutics delivery system, therefore, in this Chapter, we would 
investigate the preparation of nanocapsules based on polystyrene particles (less than 
200 nm) and some further functionalisation of these nanocapsules. 
In this Chapter, firstly the synthesis of the polystyrene particles (around 130 nm) is 
discussed. Then, the preparation of nanocapsules consisting of biocompatible 
polyelectrolytes (CHI/DS) and laponite is demonstrated. Finally, the fabrication of the 
nanocapsules functionalised by gold/magnetite particles is also discussed. 
 
6.1 Materials 
The chemicals involved in this experiment were: Sodium Chloride (99.5% Sigma 
Aldrich), Chitosan (CHI) (50,000-190,000Da, Aldrich), Dextran Sulfate Sodium Salt 
(DS) (approximate 10,000Da, Sigma), laponite (Rockwood additives), 
Tetrahydrofuran (THF, ≥99%, Aldrich), Hydrogen Tetrachloroaureate (III) Trihydrate 
(HAuCl4, 99.99%, Acros Organics), Tetrakis(hydroxymethyl)phosphonium Chloride 
(THPC, 80% in water, Fluka), Sodium hydroxide (NaOH, semiconductor grade, 
Aldrich), Iron (II) chloride tetrahydrate (FeCl2∙4H2O, 99%, Sigma-Aldrich), Iron (III) 
chloride hexahydrate (FeCl3∙6H2O, BDH), Sodium Oleate (C17H33COONa, BDH). All 
water used was deionised. The visking dialysis tubing (MWCO-12-14000 Daltons, 
diameter 38.1 mm and 6.3 mm) used here was obtained from the Medicell 
International Ltd.  
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6.2 Methodology 
6.2.1 Synthesis of Polystyrene Nanoparticles 
The procedure of preparing size around 100 nm polystyrene nanoparticles followed 
the same basic styrene polymerization procedure described in Chapter 5 section 5.2.1 
with only a few changes to the method. Firstly, the reaction volume was enlarged to 2 
L. Secondly, except for adding the deionised water, styrene monomer and NaCl, 
sodium dodecylbenzene sulphonate (SDBS) as a surfactant was also added into the 
system. It is well known [236] that the addition of surfactant reduces the particle size of 
PS particles. Therefore, in this case, 1650 ml water, 100 ml styrene monomer and 2.5 g 
sodium dodecylbenzene sulphonate was initially added into the flask. Then, after 
vigorous stirring, the initiator solution (2.5 g potassium persulphate in 250 ml water) 
was added to make this reaction take place and the total volume reached to 2 L. Thirdly, 
the temperature of the water bath was raised from 80 
O
C to 85 
O
C. 
 
6.2.2 Fabrication of Nanocapsules via Layer-by-Layer 
Self-assembly Method 
6.2.2.1 Preparation of the Polyelectrolyte Solutions 
Biocompatible polyelectrolytes: CHI and DS were employed in this experiment to 
prepare nanocapsules based on polystyrene nanoparticles. The concentration of the 
polyelectrolyte solution is 1 mg/ml in 0.1 M NaCl solution. For CHI, the solution was 
also adjusted to pH 3 by HCl. Laponite was also used in this experiment as a layer 
material to strengthen the capsules. The laponite particles were dispersed in 
de-ionized water with a concentration of 10 mg/ml. 
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6.2.2.2 Preparation of the Nanocapsules 
Two types of nanocapsules have been prepared in this experiment. One of them 
consisted of 10 layers of biocompatible polyelectrolyte (CHI/DS), whereas the other 
contained 9 layer of biocompatible polyelectrolyte (CHI/DS) and one layer of 
laponite.  
 
The methodology was as follows: 5 ml of polystyrene particles (1.8 wt%) was mixed 
with 10 ml 1 mg/ml of CHI (dissolved in 0.1 M NaCl solution) and 10 ml de-ionized 
water. Then the mixture was gently shaken for 60 min before 2 
centrifugation-redispersion cycles (the particle suspension was centrifuged at 3000 g 
and 5472 g for 5 min, and finally 8425 g for 15 min) applied. Then all residue obtained 
from the centrifugation process were re-dispersed in 15 ml de-ionized water. The rest 
of the layers (except the laponite layer) were added in the same way.  
 
For the second type of nanocapsules, laponite was used as the fourth layer. For the 
deposition of the laponite layer, the 3-layer coated particle suspension was diluted to 
20% of the original concentration. Then to 5 ml of the diluted sample was added of 5 
ml 10 mg/ml laponite and 20 ml de-ionized water. The coating and wash cycle was as 
same as described above for the first layer. After the laponite layer, further layers 
were added in the same way.  
 
6.2.2.3 Functionalizing the Coated Polystyrene Nanoparticles 
In this section, two inorganic nanoparticles were introduced to add possible 
functionality to the coated polystyrene nanoparticles and subsequent nanocapsules. 
One of them was gold nanoparticles and the other one was magnetite nanoparticles. 
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6.2.2.3.1 Preparation of Gold Nanoparticles 
The gold nanoparticles were prepared by the THPC method introduced by Duff et al 
[237]. The method was to reduce HAuCl4 by using the reducing agent 
tetrakis(hydroxymethyl)phosphonium chloride (THPC). The method was as follows: 
 Firstly, 2 ml of 25 mM HAuCl4 solution was prepared and stored (dark-aged) 
for 3-4 days (Fig. 6.1).  
 1.2 ml THPC (80% aqueous) was then added into 100 ml of de-ionized water. 
  1 ml of this solution was mixed with 0.5 ml of 0.1 M NaOH solution and 
de-ionized water was added to fix the volume to 50 ml.  
 Finally, 50 ml of this solution was mixed with the dark-aged HAuCl4, and the 
dark brown gold nanoparticle suspension was obtained (Fig. 6.2). 
 
 
Fig. 6.1 Dark-aged HAuCl4 solution 
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Fig. 6.2 Gold nanoparticle suspension 
6.2.2.3.2 Preparation of Magnetic Nanoparticles 
The method used in this experiment to produce magnetic nanoparticles was that 
introduced by Sun et al [222].  
 Firstly, 1.99 g (0.01 mol) of FeCl2·H2O and 5.41 g (0.02 mol) of FeCl3·6H2O 
were dissolved in 50 ml of de-ionized water.  
 Then the mixture was stirred vigorously and 1.5 M NaOH solution was added to 
adjust the pH to 11. The solution was kept vigorously stirred for another 60 min 
to ensure complete crystallization. The whole system, during the experiment, 
was kept in a water bath of 50℃, whilst adding the NaOH solution, it was 
noticed the colour of the solution changed from light brown to dark brown and 
finally to black which indicated the formation of the magnetite particles.  
 The particle suspension was centrifuged and the particles were then 
re-dispersed in the same volume of de-ionized water.  
 
The experiment was then modified and 3v% of 0.1M sodium oleate was added into 
the Fe solution as a surfactant to produce better-dispersed Magnetic particles. This 
surfactant was added before the addition of the NaOH solution. 
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6.2.2.3.3 Functionalisation of Polyelectrolyte Coated Polystyrene 
Nanoparticles with Gold and Magnetic Nanoparticles 
The gold particles were negatively charged in the suspension, so they were used as an 
even layer of the nanocapsules. Due to the presence of sodium oleate, the magnetite 
particles were positively charged and were used as an odd layer of the nanocapsules. 
 
In this experiment, 10 ml of magnetic particles were mixed with 25 ml of 10-layer 
coated polystyrene nanoparticles (9 layers of biocompatible polyelectrolyte and 1 
layer of laponite) suspension. Then the mixture was gently shaken for 1hr and the 
excess magnetic particles were removed by 2 centrifugation-re-dispersion cycles. The 
gold particles were added when the polystyrene particles were coated with 8-layers of 
biocompatible polyelectrolyte and one layer of laponite, and the coating procedure 
followed the one outlined above for the magnetite. 
6.2.2.3.4 Core Removal 
After all the coating processes, the coated particles were dissolved in THF to remove 
the polystyrene core templates. Each of the coated particle suspensions was mixed with 
twice the volume of pure THF, and the mixture was kept sealed in a fume cupboard for 
48 hrs. After dissolution, in order to get remove the THF and polystyrene residue, the 
solution was decanted into the dialysis tubings (diameter 6.3 mm and both ends tied up 
after loading) and the loaded tubing was placed in deionised water. The deionised water 
was changed every 12 hr for 7 days.  
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6.3 Results and Discussion 
6.3.1 Polystyrene Nanoparticles Synthesized with 
Surfactant 
In this experiment, polystyrene particles with size range lower than 200 nm were made 
by the polymerization of styrene monomers Both a CPS disc centrifuge (experimental 
details in Chapter 3) and dynamic light scattering were utilised to investigate the size 
distribution of these nanoparticles. From Fig. 6.1 and Fig. 6.2, it is clearly demonstrated 
that the majority of the polystyrene particles from this synthetic method shared an 
average particle size around 130±30 nm  
 
 
Fig. 6.1 Result from CPS disc centrifuge analysis: polystyrene nanoparticles (synthesized by 
polymerization of styrene monomers with the presence of SDBS) size distribution 
 
 
 126 
 
  
 
Fig. 6.2 Result from dynamic light scattering analysis: polystyrene nanoparticles (synthesized by 
polymerization of styrene monomers with the presence of SDBS) size distribution  
 
SEM was also employed in this characterization section to further investigate the shape, 
surface and size distribution of the polystyrene nanoparticles (130 nm) (Fig. 6.3).  
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Fig. 6.3 SEM micrograph of polystyrene particles prepared by polymerization of styrene 
monomers with the presence of surfactant SDBS 
 
Compared with the polystyrene particles with larger size (Chapter 5 Fig. 5.5), these 
polystyrene particles were more poly-dispersed and also seem softer, as drying forces 
seem to have deformed the particles. This is likely to be due to the SDBS plasticizing 
the polystyrene. For the purpose of using these particles as a template, however, this is 
immaterial. Likewise the wider size distribution did not make the suspension 
inappropriate for use as a LBL template; indeed in many respects a polydispersed 
template has the advantage of investigating the behaviour of a variety of different 
particle sizes in just one experiment.  
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6.3.2 Nanocapsules Consisting of Polyelectrolyte and 
Laponite 
6.3.2.1 Salt Concentration of the Polyelectrolyte Solution 
Before coating with the polyelectrolyte, 3 different sodium chloride concentrations 
(0.1 mol/ml, 0.5 mol/ml and 1.0 mol/ml) were tested for the first layer deposition. It 
was found that for 0.5 mol/ml and 1.0 mol/ml, the coated polystyrene particles were 
hard to re-disperse and a few aggregates were found in the suspension. This 
aggregation may be due to the relatively small particle size compared to the layer 
thickness and that the capsules entangled together during centrifugation. Therefore, in 
this experiment, 0.1 M NaCl was used to prepare the polyelectrolyte solutions.  
 
6.3.2.2 Biocompatible Polyelectrolyte 
There were 2 types of nanocapsules prepared in this section: with or without laponite 
layer. For the nanocapsules without the laponite layer, 10 layers of biocompatible 
polyelectrolyte were added onto the polystyrene nanoparticles. While the ones with 
laponite layer were prepared in the same way, only the fourth layer was changed from 
DS to laponite. Fig. 6.4 and Fig. 6.5 show the zeta-potential of each layer of the 2 
samples. 
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Fig. 6.4 Zeta-potential of layers of nanocapsules consisting of 10 layers biocompatible 
polyelectrolyte ((CHI/DS)5);The values are given in the appendix Table A.7. 
 
 
Fig. 6.5 Zeta-potential of layers of nanocapsules consisting of 9-layer of biocompatible 
polyelectrolyte (CHI/DS) and laponite (the 4
th
 layer); The values are given in the appendix Table 
A.8. 
 
From Fig. 6.4 and Fig. 6.5, the deposition of each polyelectrolyte layer was confirmed 
by the changes of the zeta-potential. It can be noticed in both graphs, that the 
zeta-potential decreased during the Layer-by-layer deposition process. It is also been 
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noticed the zeta-potential (absolute value) of the laponite layer (4
th
 in Fig. 6.5) is 
lower than the corresponding layer in Fig. 6.4. This may be due to either the steric 
effect leading to less deposition of laponite nanoparticles compared to DS, or due to 
he lower zeta potential of laponite.  
 
After the coating process was complete, the 2 samples were observed under SEM and 
the micrographs of the coated particles are shown in Fig. 6.6 and Fig. 6.7. 
 
 
Fig. 6.6 SEM micrograph of polystyrene particles coated with 10 layers of biocompatible 
polyelectrolyte 
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Fig. 6.7 SEM micrograph of polystyrene particles coated with 10 layers of biocompatible 
polyelectrolyte and where the 4
th
 layer is laponite 
From Fig. 6.6 and Fig. 6.7, no obvious difference can be found from the 2 pictures. 
The roughness of each particle surface seems similar and all the particles attached 
together and formed clusters of particles. The appearance of the clusters may be 
because the density of the particles is relatively large and after dried, the coated 
particles cannot stay flat in the surface and formed this kind of particle clusters. The 
similar roughness can be explained by the 6 more added polyelectrolyte layers can 
possibly smooth out the rough surface of the laponite layer and gave the particles a 
similar appearance of the particles coated with only polyelectrolyte. However, 
although the roughness of both samples seems similar, it is still rougher compared 
with the original polystyrene particles, which is further evidence of the formation of 
relatively thick polyelectrolyte layers 
 
6.3.2.3 Core Removal 
After being coated with polyelectrolyte and laponite layers, the 2 samples (prepared in 
the last section) were dissolved in THF (volume ratio1:2) to remove the polystyrene 
core templates.   
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For the particles coated with 10 layers of biocompatible polyelectrolyte, only a few of 
nanocapsules were found after the core removal process (Fig. 6.8).  
  
Fig. 6.8 TEM micrographs of nanocapsules derived from 10-layer coated polystyrene 
nanoparticles of different magnification (no laponite attendance), the size of the left scale bar is 
200 nm and the size of the right scale bar is 50 nm 
From Fig. 6.8 the nanocapsules obtained from the core removal process can be clearly 
observed. The capsules were light grey in colour and the black areas in some of the 
nanocapsules can possibly be the residue of the polystyrene particles. It can also be 
noticed that the shape of the nanocapsules was not spherical anymore and more like a 
deflated balloon. The change of the shape indicated the change inside of the capsules 
(core removed). Because there was no laponite layer of the capsule, and without the 
support of the core template, the capsule itself would possibly change its form from 
spherical to irregular. 
 
After core removal, the nanocapsules derived from the polystyrene particles coated 
with 9 layer of polyelectrolyte and 1 layer of laponite were also observed under TEM 
(Fig. 6.9). Many more capsules were now visible 
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(a)                               (b) 
 
Fig. 6.9 TEM micrographs of nanocapsules derived from 10-layer coated polystyrene 
nanoparticles of different magnifications (the 4
th
 layer is laponite), the size of the left scale bar is 
100 nm, and the size of the right scale bar is 50 nm 
 
From Fig. 6.9 b, it can be clearly seen that an incompletely removed polystyrene 
particles was surrounded by several nanocapsules obtained from the core removal 
process. The dark area in the middle of the picture is the un-removed polystyrene 
particle, and there are 3 empty nanocapsules around it. In Fig. 6.9 a, more 
nanocapsules obtained from the core removal process can be observed. Although 
there were some of the nanocapsules collapsed or formed the cup-shape nanoparticles, 
most of the nanocapsules survived from the THF erosion and kept their spherical 
shape. Compared with the nanocapsules without laponite layer, it can be noticed that 
the productivity of the nanocapsules with one layer of laponite is relatively higher. 
Therefore only the particles coated with 9-layer of polyelectrolyte and 1 layer of 
laponite were used in the functionalization with gold and magnetic nanoparticles. 
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6.3.3 Functionalization of the Nanocapsules  
Coating with some inorganic particles would change the property of the nanocapsules. 
In this experiment, gold and magnetite particles were prepared and added onto the 
coated polystyrene nanoparticles to make the nanocapsules sensitive to infrared (in the 
case of gold nanoparticles enabling the particles to be heated by near IR radiation) and 
easy to locate and visualise the nanocapsules (in the case of magnetic particles) during 
the drug delivery process. 
 
6.3.3.1 Gold Nanoparticles Deposition 
6.3.3.1.1 Characterization of the Gold Nanoparticles 
The gold nanoparticles used in this experiment were prepared by reducing HAuCl4 
with a reducing agent tetrakis(hydroxymethyl)phosphonium chloride (THPC). The 
gold nanoparticles were characterized by Zeta meter, TEM and CPS disc centrifuge. 
 
The zeta-potential of the gold nanoparticles was -29±2 mV which indicates the gold 
nanoparticles should be used as an even layer of the nanocapsules. The data obtained 
from CPS disc centrifuge showed the size range of the gold nanoparticles was between 
4-10 nm.  The TEM picture of the gold nanoparticles is shown in Fig. 6.10. 
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Fig. 6.10 TEM micrographs with different magnifications of gold nanoparticles; the scale bar of 
the left micrograph is 20 nm and it is 5 nm for the right one 
 
From the TEM pictures in Fig. 6.10, the size distribution of the gold nanoparticles can 
be roughly observed. Except for a few large particles, most of the particles were under 
10 nm. Compared with the diameter of the polystyrene nanoparticles, the size of the 
gold nanoparticles is small making them suitable as an alternative to an anionic 
polyelectrolyte and so have the particle to be used to deposit a monolayer onto the core 
particle. 
 
6.3.3.1.2 Deposition of Gold Nanoparticles 
Due to the negative charge, the particles were added onto the 9-layer coated 
polystyrene particles. The zeta-potential of the particles changed from 23±2 mV to 
-15±3 mV, which indicated the deposition of the gold nanoparticles. The TEM picture 
of gold coated polystyrene nanoparticles, coated with 8 polyelectrolyte layers and one 
laponite layer (4
th
 layer), is shown in Fig. 6.11. 
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Fig. 6.11 TEM micrograph of polystyrene particles (8 layers polyelectrolyte and the 4th layer is 
laponite) coated with gold nanoparticles, the scale bar in the graph is 20 nm 
In Fig. 6.11, a thin and fine layer of gold was observed on the polystyrene 
nanoparticles. However, it can be noticed that the coverage of the gold layer is not 
very high compared with the polyelectrolyte. That can explain the low zeta-potential 
(absolute value) of the gold coated nanoparticles.   
After core-removal process, the gold coated nanocapsules can be seen from Fig. 6.12. 
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(a)                                (b) 
 
Fig. 6.12 TEM micrographs of nanocapsules (after dissolving by THF for 48 hr) of 8-layer 
polyelectrolyte (CHI/DS), one layer laponite (4
th
 layer) and the outer layer is gold, the scale bar in 
the left graph is 100 nm and the scale bar is 20 nm in the right graph 
The nanocapsules coated with gold nanoparticles can be observed in Fig. 6.12. 
Compared with particles in Fig. 6.11, the shape of the nanocapsules (after core 
removed) and the coverage of the gold particles did not change significantly.  
 
6.3.3.2 Magnetic Nanoparticles Deposition 
6.3.3.2.1 Characterization of the Magnetic Nanoparticles 
Magnetic Property 
The magnetic property of the magnetic particles was assessed directly by the method 
illustrated in Fig. 6.13. 
 
From the difference between Fig. 6.13 a and b, the attraction of the magnetic particles 
to the magnetic stirrer can be clearly noticed, demonstrating the magnetic properties 
of the particles. The nanocapsules coated with the magnetic particles have the 
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potential to be traced and directed in the human body using magnetic resonance 
imaging, and so could be used for targeting purposes. 
(a)                                     (b) 
         
Fig. 6.13 The test of the magnetic property of the magnetite nanoparticles. (a) The magnetic 
particle suspension; (b) The magnetic particle suspension stimulated by a permanent magnetic 
stirrer. 
Zeta-potential 
Since the Layer-by-layer method employed in this experiment is based on 
electrostatic force, the zeta-potential of the particles is another important property of 
the magnetic particles. The zeta potential of the particles produced with sodium oleate 
was +31±3 mV and it was -27±2 mV of the ones without sodium oleate. 
 
XRD Analysis 
The two samples were also analysed by XRD analysis (Fig. 6.14). 
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Fig. 6.14 The XRD patterns of magnetic particles with or without sodium oleate. (Blue line: 
without sodium oleate; red line: with sodium oleate; the straight vertical black line: pure 
magnetitie) 
From Fig. 6.14, the XRD patterns of the 2 magnetic particles (Blue and red patterns) 
are roughly coincident to that of that pure magnetite (the vertical black lines at the 
bottom of the graph) (ICDD No. 19-0629), which confirmed the preparation of the 
magnetite particles in this project. Comparison between these two patterns shows that 
the diffraction pattern of the magnetite particles prepared without sodium oleate is 
more similar to the pattern of the pure magnetite, whereas for the magnetite particles 
prepared with sodium oleate, two characteristic peaks at about 31
o
 and 45
o
 was 
observed in Fig. 6.14 (spotted on the red pattern). According to the XRD data provided 
by the technician, who assisted in taking these patterns, those two peaks are 
characteristic peaks of sodium which was probably introduced by sodium oleate. 
Peaks selected to calculate the size of the 
particles 
Peaks aroused due to the presence of 
sodium 
Vertical black lines (straight up from the 
bottom): characteristic pattern of pure 
magnetite 
XRD pattern of the magnetite particles 
prepared with sodium oleate 
XRD pattern of the magnetite particles 
prepared without sodium oleate 
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Compared with the XRD pattern of the magnetite nanoparticles prepared by Sun et al. 
[222] (Fig. 6.15), it could be noticed that the two patterns obtained in this experiment 
are very similar to the result of Sun et al. 
 
Fig. 6.15 The XRD pattern of the magnetite prepared by Sun et al. [222] 
 
As reported in the Chapter 3 section 3.5, when the crystallite domains of the materials 
are less than 100 nm, this domain could correspond to the real size of the particles and 
the size of the domain could be estimated based on the wave length of X-ray and half 
the maximum intensity in radians [223]. Therefore, by the Scherrer equation (Equation 
6. 1), the mean particle diameter of the 2 samples can be estimated (Table 6.1).  
 
Equation 6. 1            
  
     
 
where K is the shape factor (0.9 was taken here), λ is the x-ray wavelength of the X-rays, 
β is the line broadening at half the maximum intensity (FWHM) in radians (in this case, 
the characteristic peaks (30
O
-40
O
) of magnetite particles were picked), and θ is the 
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Bragg angle; τ is the mean size of the ordered (crystalline) domains, which may be 
smaller or equal to the grain size [238, 239]. 
Table 6.1 Estimation results of the particle average size of the magnetite particles 
   With sodium oleate Without sodium 
oleate 
β(radians) 
2θ (o) 
τ (nm) 
 0.01438 
35.54 
10.0 
0.01436 
35.48 
9.6 
 
For the unknown particles, the typical value of dimensionless shape factor K of the 
crystalline domains (τ) is 0.9 [238, 239], therefore the size of the magnetite particles 
with sodium oleate is about 11.1 nm and the ones without sodium oleate is about 10.7 
nm.  
 
TEM Analysis 
The 2 batches of magnetic nanoparticles were both observed under the TEM. And the 
TEM pictures are shown in Fig. 6.16.         
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(a)                                     (b) 
 
Fig. 6.16 The TEM micrographs of the magnetic nanoparticles (a) prepared with sodium oleate 
(b) prepared without sodium oleate 
 
From Fig. 6.16, the shape and size of the magnetic particles can be easily observed. 
The particles demonstrated in the TEM pictures are from several nanometers to 
almost 20 nm. This size range corresponds to the mean diameter (around 10 nm) 
calculated from the XRD pattern. Although there is no obvious difference found 
between these two samples, there are some needle-like particles in Fig. 6.16 (b), 
which makes the magnetic particles prepared with sodium oleate a better option for 
the nanocapsules preparation. In theory, the presence of the sodium oleate (as a 
surfactant) would help to form magnetic particles with a narrower size distribution, 
therefore, the magnetite particles prepared with sodium oleate was used as a layer 
material for the nanocapsules fabricated on the polystyrene particles. 
 
 6.3.3.2.2 Deposition of the Magnetite Nanoparticles 
Due to the positive charge of the magnetite nanoparticles, the particles were mixed 
with the 10-layer sample (9 layers of biocompatible polyelectrolytes and 1 layer of 
laponite) to prepare the functionalise nanocapsules. After the coating and centrifuge 
cycle, the zeta-potential of the coated polystyrene nanoparticles shifted from -37±3 
mV to +4±2 mV. The zeta-potential was not very high for the LBL self-assembly 
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method. The reason of the low zeta-potential value can be explained by the TEM 
pictures of the coated particles (Fig. 6.17). 
 
Fig. 6.17 TEM micrographs of 10-layer coated polystyrene sample coated with one layer of 
magnetite nanoparticles (prepared with sodium oleate), the scale bar is 50 nm 
 
From Fig. 6.17, it can be clearly seen that the deposition of the magnetic nanoparticle 
layer was incomplete. There was only about 10-20% of the polystyrene particle 
surface covered by the magnetic nanoparticles. The reason for such a low coverage 
may be explained by the magnetic property of those nanoparticles. Due to the 
magnetic property, the magnetite nanoparticles formed some micro-aggregates in the 
suspension those micro-aggregates were not easily fully re-dispersed. Therefore, after 
the coating process, only those micro-aggregates and a few single particles attached to 
the surface of the polystyrene nanoparticles. Furthermore, such a low coverage led the 
zeta-potential having a very low level, which was close to 0. However, despite the 
low coverage, the magnetic particles attached onto the polystyrene particle surface 
can still provide a weak magnetic property. And if the external magnetic field (for 
example, in an MRI scanner) is strong enough, those nanocapsules could be monitored 
or directed inside the human body. 
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After the-core removal process, the nanocapsules coated with magnetic nanoparticles 
was analysed by TEM. The TEM pictures of the nanocapsules are shown in Fig. 6.18. 
(a)                              (b) 
   
Fig. 6.18 TEM micrographs of nanocapsules consisting of 9-layer polyelectrolyte, one layer of 
laponite and one layer of magnetic nanoparticles, the scale bar in both graphs is 200 nm 
 
From Fig. 6.18, only a few of nanocapsules were found after the core removal process. 
There may be 2 reasons to explain the disappearance of the nanocapsules. The first 
one is that after coated with magnetic particles the property of the nanocapsules were 
slightly changed and not strong enough to survive from the THF erosion. The other 
one is that after the core removal, the population density of the nanocapsules was 
much less than before and due to the little amount of sample used in the TEM analysis, 
the concentration of the nanocapsules did not represent the whole system. However, 
some nanocapsules can still be observed. In the Fig. 6.18 (a), a capsule attached with 
a cluster of magnetic particles can be seen and the shape of the nanocapsule did not 
change obviously. In Fig. 6.18 (b), there are 2 nanocapsules. One of them was coated 
with magnetic nanoparticles and the coverage is higher than the one in Fig. 6.18 (a), 
however, the shape of the capsule became irregular after the core-removal. There are 
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no obvious magnetite particles coated on the other nanocapsule, but the capsule 
remained spherical after the core removal process. 
 
6.4 Conclusion 
As a follow on from Chapter 5, in this Chapter, the polystyrene nanoparticles with 
smaller size (130 nm) were employed as core templates. The preparation of the 
polystyrene particles was almost the same as it was in Chapter 4 except for the adition 
of the surfactant sodium dodecylbenzene sulphonate (SDBS), to reduce the particl 
size.  Following the same Layer-by-Layer process used in the Chapter 4, two 
different core-shell structures were obtained. The first one was 5 bi-layer of 
polyelectrolyte: CHI/DS; while the other one was roughly the same composition only 
that the 4
th
 layer was replaced by laponite. After dissolving in THF, the results 
showed that the capsules with a layer of laponite were mechanically more robust as 
most of the particles survived the dissolution of the polystyrene core by THF. 
Therefore, the core-shell structure with a layer of laponite was chosen for further 
modification in this Chapter. Two inorganic particles: gold and magnetite particles 
were prepared in this experiment; the gold particles had a size range of 4-10 nm; 
while the size was around 10 nm for the magnetite particles. Both inorganic particles 
were utilised as the outer layer to deposit onto the polystyrene particles which were 
already coated with polyelectrolytes and laponite: 8 layers of polyelectrolyte: CHI/DS 
and one layer of laponite for gold particles and 9 layers of polyelectrolyte: CHI/DS 
and one layer of laponite for magnetite particles. It was found that the coverage of the 
gold nanoparticles was higher and more even than that of the magnetite particles. That 
might be due to the gold particles were relatively smaller and had more regular shape 
than the magnetite particles. Finally, after the core-removal process, nanocapsules 
both covered with gold or magnetite particles were attempted to be fabricated. The 
gold coated nanoparticles were particularly well formed. 
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Chapter 7 Nanocapsules Consisting of 
Proteins and Polyelectrolyte 
Multiple protein layers attached to solid surfaces have been broadly used in the areas 
of isolation, localisation and diagnostics in biotechnology [172]. Therefore, in this 
Chapter, the preparation of nanocapsules consisting of polyelectrolyte (pre-coating) 
and proteins will be discussed. The first part describes the preparation of nanocapsules 
with protein walls that were built on polystyrene core-templates and the second 
concerns the preparation of insulin nanoparticles and coating polyelectrolyte and 
protein layers onto those particles.  
 
7.1 Nanocapsules Consisting of Proteins via 
Polystyrene Nanoparticles 
7.1.1 Materials 
The chemicals involved in this experiment were: Poly(diallydimethylammonium 
chloride) (PDADMAC) (20 wt% in water, Sigma Aldrich), Sodium Chloride (99.5% 
Sigma Aldrich), Dextran Sulfate Sodium Salt (DS) (Sigma), Tetrahydrofuran (THF), 
≥99%, Aldrich), Bovine Serum Albumin (BSA) (≥98% (agarose gel electrophoresis), 
lyophilized powder, CAS Number 9048-46-8, molecular weight 66 kDa, 
Sigma-Aldrich), Lysozyme (from chicken egg white, dialyzed, lyophilized powder, 
100000 U/mg, mol wt 14.3 kDa, CAS Number 12650-88-3, EC Number 235-747-3, 
Sigma-Aldrich), Buffer solution of pH 7.4 (Sigma-Aldrich), Buffer solution of pH 9.2 
(BDH Chemicals Ltd.), Buffer solution of pH 10 (BDH Chemicals Ltd.), Polystyrene 
particles 480 nm ( Prepared in Chapter 5), all water used was de-ionised water. 
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7.1.2 Methodology 
7.1.2.1 Preparation of Polyelectrolyte Solutions and Protein 
Solutions 
The polyelectrolyte solutions employed here were PDADMAC and DS. The reason 
why PDADAMAC was chosen over CHI is because PDADMAC can provide a 
relatively high value zeta-potential which was better for the protein layers to add on, 
and did not need to be acidified to become soluble. The PDADMAC and DS solution 
contained: 1 mg/ml polyelectrolyte, 0.1 M NaCl. 
 
Two protein solutions: BSA and lysozyme were used here to make layers of the 
nanocapsules. The concentration of BSA solution is 2 mg/ml and for lysozyme solution, 
it is 4 mg/ml. All the proteins were dissolved in the pH 7.4 buffer solution. The pH 
measurement was described in Chapter 4 section 4.2.2: and each measurement of 
sample’s pH was repeated one time to ensure the accuracy of the data (difference not 
larger than 0.1).  
 
Bovine Serum Albumin (BSA) is a blood serum protein which has numerous  
applications including ELISAs (Enzyme-Linked Immunosorbent Assay), immunoblots, 
and immunohistochemistry [240]. The amino acid sequence of BSA is known and it is 
known to be sensitive to temperature changes and tends to agglomerate (which is 
irreversible) when the temperature increases [241]. The general structure of BSA is 
shown in Fig. 7.1. The isoelectric point (IEP) of BSA is 4.7 [241] and so this protein is 
negatively charged at pH 7.4.  
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Fig. 7.1 The general structure of BSA [241] 
 
Lysozyme is an of enzyme that can damage bacterial cell walls by hydrolyzing the 
polysaccharide component of the cell wall, which is part of the innate immune system, 
where it has been shown that an insufficient level of Lysozyme is associated with 
bronchopulmonary dysplasia in newborns [242]. It is normally found in secretions such 
as tears, milk, and saliva and is also present in egg white [243]. The general structure of 
lysozyme is shown in Fig. 7.2. The Isoelectric point of lysozyme is around pH 10.7 
[244] and so this protein is positively charged at pH 7.4.  
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Fig. 7.2 The general structure of lysozyme [244] 
 
7.1.2.2 Layer-by-Layer Self-assembly 
The polystyrene particles with size range 483  31 nm (prepared in Chapter 5 2.5 wt %) 
were used as core templates. To further confirm the proper number of pre-coated PE 
layers for lysozyme and BSA deposition. Three different samples which consisted of 
different numbers of polyelectrolyte layers (0, 1 and 3 layers respectively) were 
prepared via the LbL process. For the capsules consisting of polyelectrolyte and 
proteins, 2 batches of particle precursors were prepared before the protein’s deposition: 
The first one was coated with 3 polyelectrolyte layers (PDADAMAC/DS/PDADMAC) 
and the other is coated with only one layer of PDADMAC. For the polymer layers, 5 ml 
of polystyrene particles were mixed with 10 ml of polyelectrolyte solution (1 mg/ml 0.1 
M NaCl) and 10 ml of deionised water. Then the mixture was gently shaken for 1 hr. 
After shaking, the sample was centrifuged by a series of steps to separate the excess 
polymers from the coated particles (which followed the same process as that described 
in Chapter 5). Eventually the remaining particles were re-dispersed in 15 ml of 
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de-ionised water. After all the pre-coating layers, the particles were exposed to protein 
solutions to fulfil the whole LBL Self-assembly process. For the protein deposition, the 
procedure was the same, only the pH was adjusted to the desired pH. Unless otherwise 
stated all the solutions were of phosphate buffered saline solutions, at pH 7.4. The 
concentration of BSA solution was 2 mg/ml and for lysozyme was 4 mg/ml of protein. 
For the capsules consisting only of proteins, lysozyme was the first layer, and the same 
deposition method for the polyelectrolyte layers was adopted. 
 
7.1.2.3 Core Removal 
After the fabrication of the polymer and protein layers, the coated particles were treated 
with THF to dissolve the core templates. The volume ratio of the particle dispersion to 
THF was 1:2, and the mixture was kept for 48 hrs. After the dissolving, in order to 
remove the THF and polystyrene residue, the solution was centrifuged, re-dispersed in 
de-ionized water, and then dialyzed against de-ionized water. (See Chapter 5 for further 
details) 
 
7.1.3 Results and Discussion 
7.1.3.1 Salt Concentration 
As it was mentioned in Chapter 5, 0.1 M NaCl was the electrolyte concentration used 
for the polyelectrolyte solutions to prepare the precursors for proteins deposition. 
 
7.1.3.2 The pH Effect on Protein Deposition 
As reported in the literature review, at room temperature, the structure and charge of 
protein mainly depend on the pH value of the solution [245]. Due to the presence of 
ionic functional groups (-COOH and –NH2), at a certain pH a protein molecule will be 
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zero charged (called Isoelectric Point: IEP). For any pH value above Isoelectric Point, 
the protein molecules will be negatively charged while positively charged if it is below. 
The IEP value for BSA and Lysozyme is 4.7 [241] and 10.7 [244]. Therefore, a pH 
value between 4.7-10.7 ought to make BSA and Lysozyme charged oppositely. 
Therefore, 3 buffer solutions (pH7.4, pH9.2, pH10) were tested to explore the optimum 
pH value for alternating protein layer deposition. For the BSA, since it was negatively 
charged in the solution, thus, it was employed as the forth layer (after 3 PE layers) and 
lysozyme which is positively charge was used as the fifth layer (after 3 PE layers and 
one layer of BSA). The results of the first BSA and Lysozyme layer deposition are 
given in Fig. 7.3. 
     (a) 
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    (b) 
 
Fig. 7.3 Zeta-potentials of the first protein coating (4
th
 and 5
th
 layer of the coating process) at 
different pH values (pH7.4, pH9.2, pH10) (a) BSA (b) Lysozyme;  
Zeta potential values are given in Appendix Table A.9 and Table A.10 
From Fig. 7.3, it can be clearly noticed that compared with pH 9.2 and pH 10, pH 7.4 
gave the largest difference in the zeta potential for the two proteins and so this pH was 
used for all subsequent experiments. 
 
However, it was found that after coating with the lysozyme layers, the particles which 
were re-dispersed in the de-ionized water (pH 6) exhibited a higher zeta-potential 
values than those re-dispersed in the buffer solution (pH 7.4). That is because lysozyme 
was more positively charged in a lower pH medium (DI water pH-6). Therefore, instead 
of using the buffer solution, the particles with lysozyme as the outer layer were 
re-dispersed directly into de-ionised water, which provided the coated particles a 
relatively high zeta-potential value. Thus, the final coating and re-dispersion process is 
demonstrated as Table 7.1.  
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Table 7.1 Depositing and re-dispersing solution used in the protein (BSA/lysozyme) deposition 
experiments (left: dissolving solution, right: re-dispersing solution)  
Coating layers Coating and re-dispersion 
Polyelectrolyte layers 
 
PDADMAC/BSA 
 
BSA/Lysozyme 
0.1 M Salt solution/re-dispersed in 
deionised water (pH 6) 
Buffer solution (pH 7.4)/re-dispersed in 
buffer solution (pH 7.4)  
Buffer solution (pH 7.4)/re-dispersed in 
deionised water (pH 6) 
 
7.1.3.3 Nanocapsules Self-assembly 
7.1.3.3.1 The Precursor Polyelectrolyte Film and Nanocapsules 
Fabrication 
According to Caruso [116, 172], when coating particles with layers which are not 
polyelectrolyte layers, (e.g. laponite or other inorganic particles) it is best practise to 
pre-coat the particles with at least three layers of polyelectrolyte before coating with the 
other material. Because the polyelectrolyte precursor could make the surface of the 
particle uniformly charged and smoother and this is necessary for the deposition of 
large molecules (e.g. proteins and other biomolecules) or nanoparticles (e.g. silica or 
laponite nanopatilces).  
 
To further confirm whether it was necessary for protein layers, 3 batches of samples 
were prepared: a) No pre-coating of the particles; b) 1 polyelectrolyte pre-coating of the 
particles; c) 3 layers pre-coating of the particles sample. For the pre-coating layers, 
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positively charged PDADMAC and negatively charged DS were used as odd and even 
layers and for the rest of the layers, positively charged Lysozyme and negatively 
charged BSA were employed. The results are shown in Fig. 7.4.  
 
Fig. 7.4 The zeta-potential results of protein (BSA/lysozyme) coating processes started from 
different layers of polyelectrolyte (PDADMAC/DS) precursors (0, 1, 3 layers).  
Zeta-potential values are given in Appendix Table A.11. 
 
In Fig. 7.4, the result of the zeta-potential measurement indicates that if no 
polyelectrolyte layers were present then the zeta potential of the particles containing 
protein was low and after 6 layers became zero which led to particle aggregation. 
However, one layer and 3 layers pre-coated precursors were successfully coated with 
subsequent protein layers. With suitable buffer solutions and at least one pre-coating 
polyelectrolyte layer, the zeta-potential of the protein layers were at the similar level of 
the polyelectrolyte layers, which illustrated that the stability of the protein coated 
particles was acceptable. However, for the particles without any pre-coatings, it was 
found that after 6 layers, it was difficult to coat more layers on because the 
zeta-potential fell to zero, and some aggregation was found in the suspension. 
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Therefore, after the experiment, it was concluded at least one layer of polyelectrolyte 
pre-coating needed to fabricate nanocapsules consisting of proteins.  
7.1.3.3.2 SEM Examination of the Protein Coated Particles 
All the coated polystyrene particles were examined under the SEM to observe the final 
result of the LBL self-assembly process. Fig. 7.5 to Fig. 7.7 demonstrated the SEM 
results of the 3 different samples prepared in the last paragraph.  
 
Fig. 7.5 SEM micrographs of polystyrene particles coated with 5 layers of proteins 
((lysozyme/BSA)2/lysozyme) without any polyelectrolyte layers 
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(a)                                (b) 
 
Fig. 7.6 SEM micrographs of polystyrene particles coated with 7 protein layers and 1 
polyelectrolyte (PDADMAC/(BSA/lysozyme)3/BSA) pre-coating layer 
 
(a)                                (b) 
 
Fig. 7.7 SEM micrographs of polystyrene particles coated with 5 protein layers and 3 
polyelectrolyte pre-coating layers (PDADMAC/DS/PDADMAC/(BSA/lysozyme)2/BSA) 
Comparing Fig. 7.5 with Fig. 7.6 and Fig. 7.7, the particles in Fig. 7.5 had a much 
smoother surface than those in Fig. 7.6 and Fig. 7.7. That may indicate the incomplete 
deposition of the protein layers, and explained why the zeta-potential of these particles 
fell to zero after 5 layers coating. 
 
In Fig. 7.6 and Fig. 7.7, the surface of the particles was much rougher compared with 
particles coated with only polyelectrolyte layers (presented in Chapter 5 Fig. 5.9). That 
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can be explained by the size difference between protein molecules and polyelectrolyte 
molecules. Due to the much larger size of the protein molecules, the steric interaction 
was a barrier for proteins to form a tight and smooth layer as polyelectrolyte. Also, 
protein molecules had specific 3D structure in the aqueous solution, and this structure 
can be broken down when dried out the sample for SEM test, which gave the particles a 
relatively rough surface texture. It can also be noticed that the particles with 3 
pre-coating layers of polyelectrolyte have a relatively rougher surface compared the 
ones with only 1 pre-coating layer. This may indicate that under the same 
circumstances, the particles with 3 pre-coating layers can adsorb more protein 
molecules at each stage.  In both Fig. 7.6 and Fig. 7.7 there also appear to be some free 
protein molecules, e.g. particles smaller than 20 nm. 
 
7.1.3.3.3 Core Removal 
After dissolving in the THF and dialysed in the de-ionized water, the nano-particles 
remained in the suspension were investigated under SEM (Fig. 7.8 and Fig. 7.9) to 
confirm the removal of the core templates. 
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(a)                                     (b)                                
                                
 (c)                                      (d) 
 
                     (e) 
 
Fig. 7.8 SEM micrographs of capsules prepared from polystyrene particles pre-coated with 3 
polyelectrolyte layers and 5 protein layers a) and b) core-removed capsules (deflated) larger than 
700 nm, (c)-(e) core-removed capsules smaller than 500 nm 
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(a)                                (b) 
 
Fig. 7.9 SEM micrographs capsules prepared from polystyrene particles pre-coated with 1 
polyelectrolyte layer and 7 protein layers. (a) and (b) are of different magnitude. 
For the particles with only 1 polyelectrolyte pre-coating layer, most of the 
nano-capsules cracked after the core-removal process (Fig. 7.9), whereas, the 
nanocapsules with 3 pre-coating layers survived from the THF dissolution (Fig. 7.8). 
This comparison indicates that 3 polyelectrolyte pre-coating layers were better for 
preparing nano-capsules consisting of proteins. In Fig. 7.8 (a), (b), the 2 nano-capsules 
had a “deflated balloon” shape, and combined with the result in Fig. 7.9, the removal of 
the polystyrene particles can be confirmed. Fig. 7.8 (b), it can be noticed that the 
capsules with a size over 700 nm dried down to the background while the ones around 
500 nm or less still held their original shape. In Fig. 7.8 (c)-(e). This may be because the 
capsules consisting of protein and polyelectrolyte were not as strong as the ones 
consisting of polyelectrolyte and laponite (Chapter 5). Therefore, if the capsules were 
too large it would be hard for them to keep the original spherical shape. In both Fig. 7.8 
and Fig. 7.9, some rod-shape material can be seen, but before the removal of the 
polystyrene cores (Fig. 7.6 and Fig. 7.7), there are no such materials. In this case, these 
rod shaped features might be protein residue from the cracked capsules during the 
core-removal process. 
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7.2 Fabrication of Encapsulated Insulin 
Nanoparticles 
After the preparation of the nanocapsules consisting of polyelectrolyte and proteins, 
the loading of insulin into those capsules is also discussed in this section, however, 
instead of loading insulin molecules directly into the fabricated nanocapsules, an 
alternative way which fabricates polyelectrolyte/protein nanocapsules directly onto 
the insulin nanoparticles is explored. In this method, by coating insulin particles with 
polyelectrolytes and proteins, the release rate of insulin in vivo could be controlled. 
 
7.2.1 Materials 
The chemicals involved in this experiment: Sodium Chloride (99.5% Sigma Aldrich), 
Dextran Sulfate Sodium Salt (DS) (Sigma), Bovine Serum Albumin (BSA) (≥98% 
(agarose gel electrophoresis), lyophilized powder, CAS Number 9048-46-8, molecular 
weight 66 kDa, Sigma-Aldrich), Lysozyme (from chicken egg white, dialyzed, 
lyophilized powder, 100000 U/mg, mol wt 14.3 kDa, CAS Number 12650-88-3, EC 
Number 235-747-3, Sigma-Aldrich),, Buffer solution of pH 7.4 (Sigma-Aldrich), 
Insulin (29USP units/mg, 14011-100MG, LOT#19K177657V, Pcode: 1000855643, 
CAS No. 11070-73-8) (Sigma-Aldrich). All water used is deionised water.  
 
7.2.2 Methodology 
7.2.2.1 Preparation of Insulin Nano-aggregates 
Insulin nano-aggregates (100-230 nm in diameter) were prepared by a salting out 
method. According to Fan et al [17], the optimum salting out method for insulin 
nano-aggregates was at a pH of 1.1 and a NaCl concentration of 0.6 M. Therefore, in 
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this experiment, the insulin nano-aggregates were prepared by the following the 
method: 
 0.01 of g insulin was dissolved in 5 ml HCl solution (pH1.1). 
 Then immediately after adding 0.1755 g of NaCl (0.6 M), the sample 
was stirred in an ice bath for 1 hr to make 2 mg/ml insulin nanoparticles 
suspension [17]. 
 
7.2.2.2 Fabrication of Nanocapsules onto the Insulin 
Nanoparticles 
To separate the insulin nano-aggregates Fan et al. proposed a solution in which 
polyelectrolytes Poly(α,β-l-malic acid) (PMA) and chitosan were used and combined 
with ultra-sonicating to get insulin single nanoparticles coated with PMA and chitosan 
[17]. In this project, protein lysozyme and biocompatible polyelectrolyte dextran 
sulphate (DS) were employed to fabricate the nanocapsules onto insulin nanoparticles 
as an innovation. 
 
To keep the insulin particles stable, the optimum condition (pH 1.1 0.6 M NaCl) for 
insulin precipitation was also applied in the protein and polyelectrolyte solution. 
Because BSA also salted out at the NaCl concentration of 0.6 M, lysozyme (protein) 
and dextran sulphate sodium salt (biocompatible polyelectrolyte) were employed as the 
encapsulating material, and the lysozyme and DS were also dissolved in the same 
solution (pH 1.1 0.6 M NaCl). Because insulin particles in the suspension were 
positively charged, DS (1 mg/ml negatively charged) and lysozyme (5 mg/ml 
positively charged) were used as odd and even layers respectively. 5 ml of 1 mg/ml DS 
solution were added into 5 ml insulin suspension (2 mg/ml), and the mixture was 
stirred in the ice bath for 20 min. After that, the suspension was kept in the ultrasonic 
bath for 2-5 min to ensure the separation of the insulin nanoparticles and the deposition 
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of the polyelectrolyte/protein. Then the suspension experienced 2 cycles of 
centrifugation/re-dispersion to remove the excess polyelectrolyte. The particles were 
centrifuged at 4560 g for 3 min, and re-dispersed in the solution (pH 1.1 0.6 M NaCl) 
with the aid of an ultra-sonic bath; the re-dispersion time was 5 min. Because all the 
reactions occurred at a temperature close to 0 °C, ice was added to the ultra-sonic bath 
to control the temperature below 4 °C. 
 
After coating with a DS layer, 5 ml of 5 mg/ml lysozyme was added into the suspension, 
and followed the same procedure as that used in the DS deposition. By repeating the 
deposition procedure, 8 layers of polyelectrolyte/protein nanocapsules were built onto 
the insulin nanoparticles. The 8-layer coated sample was then stored in the refrigerator. 
 
7.2.3 Results and Discussion 
7.2.3.1 Preparation of Insulin Nano-aggregates 
It had been found that pH and ionic strength were two important factors affecting 
insulin solubility [17]. It also been indicated by Fan et al. [17] that insulin would 
dissolve instantly if the pH of the solution was lower than 2.0. That is because the IEP 
of insulin is 5.5 and at low pH, insulin molecules are more highly charged, therefore, 
they are more easily to be torn apart by the water molecules. For the ionic strength, it 
has been found that 0.55 M NaCl is a critical concentration for the insulin precipitation 
[17]. Any concentration above 0.55 M would lead insulin to precipitate at the pH 1.1. 
Hence, 0.6 M NaCl and pH 1.1 were chosen to prepare the insulin nanoparticles (size 
100-230 nm) Fig. 7.10. 
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Fig. 7.10 SEM micrograph of insulin micro-aggregates salted out from suspension (0.6 M NaCl, 
pH 1.1) 
From Fig. 7.10 , it can be observed that most of the insulin particles appear aggregated 
together. Furthermore, light scattering indicated the particle size lay in the m range, 
which is different to the experiment carried out by Fan et al [17]. This difference is 
likely to be because the insulin particles tended to form some micro-aggregates in the 
suspension. However, the aggregation was reversible as by the addition of dextran 
sulphate, the insulin particles would de-aggregate and form polyelectrolyte coated 
single particles. Likewise single particles also formed during successive adsorption of 
lysozyme and more dextran sulphate layers (Fig. 7.11). As will be seen in the SEM 
images presented later, the dextran sulfate – lysozyme – ultrasonic treatment was 
successful in breaking down the insulin nanoparticle aggregates into individual insulin 
nanoparticles. 
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Fig. 7.11 Scheme of the LbL adsorption of negatively charged polyelectrolyte (black strings) and 
positively charged polyelectrolyte (grey strings) on insulin particles [17]. 
 
De-ionised water was used here to test the stability of the insulin aggregates. By simply 
re-dispersing the insulin aggregates into de-ionised water, it was found that the solution 
turned transparent, which indicated the release of insulin from the coated aggregates. It 
was therefore ensured that the acidic condition (0.6 M NaCl pH1.1) was strictly 
followed during any process involving insulin nano-aggregates. Also de-ionized water 
can be considered as a releasing medium for the future research. 
 165 
 
7.2.3.2 Encapsulation of Insulin Nano-aggregates 
7.2.3.2.1 Zeta-potential Measurement 
Zeta-potential measurements were used to monitor the deposition of dextran sulfate and 
lysozyme onto the insulin nanoparticles the results are shown in Fig. 7.12. 
 
Fig. 7.12 Zeta-potential of the layers (DS/lysozyme) of the coated onto insulin nano-particles.  
The values of the zeta-potentials are displayed in the Appendix Table A.12. 
 
From Fig. 7.12, the shift of the zeta-potential confirmed the layer deposition on the 
insulin nano-particles. The IEP of insulin is 5.5, so the insulin particles were likely to be 
positively charged in the suspension (0.6 M pH 1.1) and the bare particle zeta-potential 
was found to be 6 mV. The zeta potential of the insulin particles was low (compared 
with the polystyrene and silica particles) and accounts for the aggregation of the insulin 
nanoparticles. The zeta potential was low for the coated particles too however, the 
particles were very stable during the whole process, and no obvious aggregation was 
noticed through the whole Layer-by-Layer procedure. Although the zeta-potential was 
low, charge reversal was occurring, which illustrated most of the particle surface were 
covered with the new polyelectrolyte or protein after each coating step. 
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It can be seen from Fig. 7.12 that the zeta-potential of the first layer was relatively 
lower than the others.  This may be because at first, the insulin nano-particles formed 
micro-aggregates in the suspension and it was hard for the DS molecules to squeeze 
into the gaps between the particles and cover the whole surface. However, with the 
deposition of further layers, the insulin particle clusters separated to single insulin 
particles and more and more polyelectrolyte or protein molecules could be added onto 
the surface of these particles, which resulted in the zeta-potential staying above 5 mV 
(absolute value). 
 
7.2.3.2.2 SEM Measurement of the Coated Insulin Particles 
After being coated with 8 layers (DS/lysozyme) of polyelectrolyte and protein, the 
suspension which contained encapsulated insulin nanoparticles was dried out and 
observed in an SEM to check the result of the Layer-by-layer procedure.    
 
As was stated earlier and illustrated in Fig. 7.11, after coating with polyelectrolyte or 
protein, the insulin micro-aggregates would separate to single insulin nanoparticles 
[17]. Fig. 7.13 shows the insulin particles after the Layer-by-Layer procedure. From 
both micrographs, it can be clearly seen the insulin micro-aggregates disappeared and 
insulin single particles with a reasonably narrow distribution (50-200 nm) were well 
dispersed in the suspension.  
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         (a) 
 
         (b) 
 
Fig. 7.13 SEM micrographs of 8 layers ((DS/lysozyme)4) coated insulin nano-particles; (a) (b) 
represent different magnification 
 
NaCl 
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From micrographs 7.13 (a), some large crystals were also observed. However, it has 
been observed by Fan at el [17], that the shape of insulin particles via this salting out 
method was irregular, mainly elliptical although some can be rhombohedra [17] (Fig. 
7.14), so these large particles cannot be insulin particles. Considering the high salt 
concentration of the suspension, those large crystals are likely to be the crystals of 
sodium chloride, which were formed during the drying out process.  The size of the 
NaCl crystals varied from hundreds of nanometers to microns (Fig. 7.15). To remove 
the sodium chloride, the suspension can be centrifuged and the residue can be 
re-dispersed in the ethanol to avoid the dissolving of insulin nano-particles [17]. Fig. 
7.13 a and b show the insulin particles coated 8 layers of polyelectrolyte and protein. 
The irregular shape of the insulin particles was well observed and despite of the 
irregular shape, most of the nano-particles stayed within the size range (50-200 nm). 
 
 
Fig. 7.14 The SEM photograph of the insulin–polyelectrolyte nanoparticles with six polyelectrolyte 
adsorption cycles from Fan et al.’s work [17] 
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Fig. 7.15 Large NaCl crystals formed during the drying out process 
 
7.3 Conclusion 
In this Chapter, the preparation of nanocapsules consisting of polyelectrolyte (as 
precursor layer) and proteins was discussed. The number of precursor layers was also 
discussed and 3 paralleled experiments were carried out to testify the optimum 
number of the precursor layers. It was found 3 precursor layers of 
PDADMAC/DS/PDADMAC is optimum for the protein layers to deposit. In that case, 
nanocapsules consisting of 3 precursor layers and 5 layers of protein: BSA/ 
Lysozyme/BSA/Lysozyme/BSA were fabricated onto the polystyrene particles and 
hollow capsules were obtained after the core removal process. Furthermore, the 
application of the polyelectrolyte/protein nanocapsules was discussed. Instead of 
loading drug molecules directly into the hollow capsules, an alternative way was used 
in this experiment and insulin as the loading material was treated via salting out 
method, which produced insulin nanoparticles (50-200 nm). Then the protein and 
polyelectrolyte layers were deposited onto the insulin nanoparticles and 
protein/polyelectrolyte nanocapsules loaded with insulin crystals were finally 
prepared.     
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Chapter 8 Conclusions and Recommendations 
for Future Work 
8.1 Conclusions 
The main objective of this project was to prepare nanocapsules suitable for a drug 
delivery system. In the experiment, the Layer-by-Layer self-assembly method was 
employed and combined with core-sacrificial technique to fabricate hollow 
nanocapsules which consist of biocompatible polyelectrolytes. At first, nanocapsules of 
a relatively new size range (less than 200 nm) were prepared based on two types of 
nanoparticles: silica and polystyrene nanoparticles. Then, gold and magnetite particles 
were used in this project to functionalise the prepared nanocapsules and other 
combinations of capsule materials (which were also novel innovations of this work): 
polyelectrolyte/protein, protein/protein were also investigated. Finally, the loading of 
effective components into the capsules was achieved by encapsulating insulin 
nanoparticles with polyelectrolyte and protein. 
 
In this thesis, two types of nanoparticles: silica and polystyrene were used as core 
templates on which to prepare the required nanocapsules. Firstly, the preparation of 
these two nanoparticles was discussed. The silica nanoparticles were prepared via the 
hydrolysis of TEOS. Because TEOS and water are immiscible, ethanol was employed 
as the medium for this reaction and NH4OH was used as a catalyst. By controlling the 
ratio of NH4OH and TEOS, silica nanoparticles of different size range were produced 
(sizing from 95±14 nm to 250±38 nm). Furthermore, the reaction time was tested and 8 
hrs was found to be the minimum length for this reaction. On the other hand, the 
polystyrene particles were obtained from the polymerization of the styrene monomer. 
The initiator of the reaction was potassium persulphate; and by preparing the particles 
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with or without surfactant (SDBS), polystyrene particles of two size ranges (130±31nm, 
480±30 nm) were prepared. After the reaction both of the silica and polystyrene particle 
suspensions were dialysed against deionised water to remove any unreacted materials.  
 
The silica nanoparticles with size of 95±14 nm and 114±12 nm were chosen as core 
templates. Chitosan (CHI) and Dextran sulphate (DS) were employed as capsule 
materials to fabricate nanocapsules onto the chosen silica nanoparticles. The 
concentration of sodium chloride of each polyelectrolyte solution was verified and it 
was found the optimum concentration was 0.1 M. Also the deposition time of each 
polyelectrolyte layer was tested and a time of 15 min was found to be sufficient for 
adsorption, although onger times could be used. Following the LbL process, the 
deposition of 9 layers of polyelectrolyte (CHI/DS) was achieved and each layer’s 
deposition was confirmed by the switch of the zeta potential of the particles surface 
from negative to positive. After all layers’ deposition, the particle suspensions were 
mixed with HF/NH4F buffer solution to remove the silica nanoparticles and the hollow 
nanocapsules were obtained. However, judging from the TEM micrographs (Fig. 4.15, 
Fig. 4.17), although it was clearly seen that some hollow capsules were formed after the 
HF dissolution, some of the capsules collapsed due to the lack of strength of the 
capsules to survive the harsh dissolution conditions. In that situation, the collapsed 
capsules formed polymer residues and might crosslink the intact capsules together, 
which could possibly affect the loading and releasing procedure based on these 
nanocapsules. The reason why these capsules were easily collapsed during the erosion 
of the acid is because the size of the core templates is less than 200 nm which is much 
smaller than several hundred nanometres or even microns (as mentioned in earlier 
literature [131]), and the higher curvature of those capsules resulted in thinner thickness 
of the capsule which means weaker capsule strength. 
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Therefore, polystyrene nanoparticles were then used as core templates to prepare 
stronger nanocapsules. Except for polyelectrolytes, various materials including 
laponite, proteins, and gold and magnetite nanoparticles were also added onto the 
polystyrene particles as capsule materials.  
 
Laponite particles which are clay particles were used as capsule layers to strengthen the 
nanocapsules. By the comparison of the polystyrene particles coated with only 
polyelectrolytes, one layer of laponite and many layers of laponite, it was found, after 
the core removal, the nanocapsules comprised of only polyelectrolyte were collapsed, 
due to the insufficient strength of the nanocapsules and nanocapsules of several 
laponite layers were also collapsed and formed some bowl-shaped hollow capsules, 
which might because the wall of the capsules is too thick. In that case, the 
nanocapsules of one layer of laponite and polyelectrolyte was found to be the most 
suitable composition and in this experiment nanocapsules consisting of 5 CHI/DS 
bi-layers plus one CHI/Laponite bi-layer were obtained after the core-removal 
process. 
 
In order to functionalize the nanocapsules obtained after the removal of the 
polystyrene particles, further modifications of the capsule surfaces were attempted on 
the nanocapsules based on the polystyrene nanoparticles of 130±30 nm in this project. 
Gold nanoparticles and magnetite nanoparticles were both prepared in this experiment. 
The size of the gold nanoparticles is around 4 nm while it is about 10 nm for the 
magnetite nanoparticles. The gold and magnetite nanoparticles were deposited onto 
pre-coated polystyrene nanoparticles separately and after the core removal process, 
the nanocapsules of 4 layers of CHI/DS bi-layers plus one layer of CHI/Gold and 
those of 5 layers of CHI/DS bi-layers plus one layer of Magnetite were both obtained.   
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Then nanocapsules consisting of polyelectrolyte and proteins were prepared. It was 
found 3 precursor layers is optimum for the protein deposit. Therefore, the 
polystyrene nanoparticles (480±31 nm) were pre-coated with three layers of 
polyelectrolyte (PDADMAC/DS/PDADMAC) before any protein molecules’ 
(lysozyme BSA) deposition. In that case, nanocapsules consisting of 3 precursor 
layers and 5 layers of protein: BSA/ Lysozyme/BSA/Lysozyme/BSA were fabricated 
onto the polystyrene particles and hollow capsules were obtained after the core 
removal process. 
 
By the final part of the project, loading drug molecules into the protein/polyelectrolyte 
nanocapsules was achieved in an alternative way. Insulin which is an effective drug 
component was salted out to form nanoparticles. The nanoparticles which are within 50 
nm to 200 nm were then coated with the polyelectrolyte/protein layers and the 
nanocapsules loaded with drug molecules were finally obtained.   
 
8.2 Recommendation for Future Work 
From the results of this project, the nanocapsules consisting of biocompatible materials 
were prepared and the insulin loaded nanocapsules were also obtained. Based on the 
potential use of this area, it is suggested that some further researchin this area be 
undertaken, which is summarized as follows: 
 
1. In this project, it was found that as a core template, neither silica nor 
polystyrene were the ideal option. Silica as an inorganic core template could 
be completely removed from the inner capsule; however, due to the harsh 
conditions involved in the dissolving process, the productivity of the 
nanocapsules was relatively low, furthermore the hazardous nature of 
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hydrofluoric acid would preclude its use for drug delivery. On the other 
hand, because polystyrene is a high molecular weight material, it is hard to 
completely remove it by the chemical erosion. Therefore, new core 
materials are required to overcome those flaws. Calcium phosphate 
nanoparticles could be employed as an alternative core template because the 
monodispersed particles are easily to be prepared and could be completely 
dissolved in diluted HCl. 
 
2. As it was mentioned in the Chapter 5 and 6, the nanocapsules with a high 
strength are preferable either in surviving from the chemical dissolution or 
in the further research. Therefore, like Laponite to the polystyrene particles, 
some new materials which are not sensitive to HF could be introduced to the 
silica system to strengthen these nanocapsules. 
 
3. Based on the nanocapsules obtained both from silica and polystyrene core 
templates, the process of loading and releasing of drug molecules could be 
applied. In order to trace the drug molecules conveniently, the molecules 
with the property of fluorescence and doxyrubicin are recommended for 
initial study, due to their ready availability, modest cost, and easy 
monitoring. 
 
4. Because the insulin molecules had been successfully loaded into the 
nanocapsules of protein/polyelectrolyte, the active release process could be 
carried out in the future. By adjusting the pH and salt concentration of the 
suspension, different release rates of the insulin molecules could be 
expected. 
 
5. As the insulin molecules were pre-loaded into the nanocapsules, some 
porous nanoparticles into which insulin could be loaded could also be used 
in the future, as the required molecules can be loaded into the pores of the 
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particles before any layer deposition. This process could skip the loading 
step after the hollow capsules obtained, which assures a high loading rate of 
the required molecules. 
 
Like the gold and magnetite particles mentioned in Chapter 6, different types of 
particles or molecules are recommended for the future work to modify the surface of 
the nanocapsules, which would present new properties to those nanocapsules. For 
example, the deposition of antibody can lead the capsules more precisely to target site 
of release. 
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Appendix 
Table A.1 The zeta-potential of each polyelectrolyte layer coated on 95 nm silica particles 
(CHI/DS) 
 Number of Layers Zeta-potential(mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
-38±3 
+28±4 
-32±3 
+58±5 
-26±2 
+51±4 
-30±3 
+53±2 
-25±3 
+56±4 
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Table A.2 The zeta-potential of each polyelectrolyte layer coated on 114 nm silica particles 
(CHI/DS) 
 Number of Layers Zeta-potential(mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
-46±2 
+36±1 
-52±3 
+57±2 
-49±4 
+56±2 
-31±2 
+51±3 
-32±4 
+40±5 
 
Table A.3 Zeta-potential of polyelectrolyte layers (PE 1 mg/ml) on polystyrene particles (480 nm) 
at different salt concentrations 
 Zeta-potential 
Layer 0M NaCl 0.1M NaCl 0.5M NaCl 
Polystyrene -48±3 -45±2 -49±3 
PDADMAC +18±2 +25±3 +24±1 
DS -16±2 -48±2 -36±4 
PDADMAC +20±1 +31±3 +26±3 
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Table A.4 The zeta-potential of each coating layer (consisting of only synthetic polyelectrolytes 
PDADMAC(odd)/PSS(even)), the concentrations: PE 1 mg/ml, NaCl 0.1 M, Laponite 10 mg/ml on 
480 nm PS particles 
 Number of Layers Zeta-potential(mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
-48±2 
+45±3 
-47±1 
+52±4 
-46±4 
+49±2 
-41±3 
+52±4 
-41±3 
+48±2 
-40±4 
 
 
Table A.5 The zeta-potential of each coating layer (Consisting of synthetic polyelectrolytes and 
Laponite particles, PDADMAC/PSS/(PDADMAC/Laponite)8), the concentrations: PE 1 mg/ml, 
NaCl 0.1 M, Laponite 10 mg/ml on 480 nm PS particles 
 Number of Layers Zeta-potential(mV) 
 0  -46±2 
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1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
+43±1 
-45±3 
+52±1 
-23±4 
+46±2 
-24±3 
+50±4 
-31±2 
+46±1 
-29±4 
+46±5 
-25±3 
+36±3 
-34±5 
+36±6 
-26±4 
+32±3 
-31±5 
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Table A.6 The zeta-potential of each coating layer (Consisting of bio-compatible polyelectrolytes 
and Laponite particles, (CHI/DS)5/CHI/Laponite), the concentrations: PE 1 mg/ml, NaCl 0.1 M, 
Laponite 10 mg/ml on 480 nm PS particles 
 Number of Layers Zeta-potential(mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
-45±3 
+26±2 
-37±3 
+34±1 
-34±4 
+24±3 
-42±2 
+27±3 
-38±4 
+24±2 
-30±4 
+21±3 
-25±3 
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Table A.7 Zeta-potential of nanocapsules consisting of 10 layers of biocompatible polyelectrolyte 
((CHI/DS)5) on 130 nm PS particles 
 Number of Layers Zeta-potential (mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
-50±3 
+22±2 
-50±2 
+28±3 
-43±4 
+23±2 
-46±1 
+21±4 
-42±3 
+19±4 
-40±2 
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Table A.8 Zeta-potential of nanocapsules consisting of 9-layer biocompatible polyelectrolytes 
(CHI/DS) and one layer laponite (the 4th layer) on 130 nm PS particles 
 Number of Layers Zeta-potential(mV) 
 0  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
-48±2 
+25±3 
-50±1 
+26±2 
-34±4 
+25±3 
-42±1 
+19±2 
-39±3 
+23±2 
-37±3 
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Table A.9 The zeta-potential of the first BSA layer (4th layer after 3 polyelectrolyte layers) on PS 
cores (480 nm) at different pH environments 
pH Zeta-potential(mV) 
7.4 
9.2 
10 
-27±2 
-15±3 
-18±3 
 
 
 
Table A.10 The zeta-potential of the first Lysozyme layer (5th layer after 3 polyelectrolyte layers 
and one BSA layer) on PS cores (480 nm) at different pH environments 
pH Zeta-potential(mV) 
7.4 
9.2 
10 
+36±3 
+6±2 
-8±3 
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Table A.11 The zeta-potential of the coating process on polystyrene particles contained different 
number of pre-coating polyelectrolyte (PDADMAC/DS) layers the rest layers are proteins (BSA 
(-)/lysozyme(+)) on 480 nm PS particles 
Number of Layers Zeta-potential (mV) 
0 Polyelectrolyte 1 Polyelectrolyte 3 Polyelectrolyte 
0 -45±2 -48±3 -46±2 
1 +8±3 +28±2 +24±3 
2 -29±3 -25±3 -48±2 
3 +7±4 +27±4 +31±3 
4 -14±2 -23±3 -29±2 
5 +4±3 +32±2 +34±4 
6 0.00 -22±4 -17±3 
7 0.00 +31±4 +36±2 
8 0.00 -27±2 -25±2 
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Table A.12 Zeta-potential of the layers of coated on insulin nano-particles (DS (odd 
layers)/lysozyme(even layers)) 
Number of layers Zeta-potential(mV) 
0 
1 
2 
3 
4 
5 
6 
7 
8 
 
+7±3 
-3±2 
+18±2 
-15±4 
+7±2 
-20±3 
+6±4 
-16±3 
+5±3 
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